,G9
HTR2A,5-HT2A Antagonists?,NCGC00013841-08,F2
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G8
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G9
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,F2
NA,Calcium Channel Blocker,NCGC00014926-03,G8
NA,Calcium Channel Blocker,NCGC00014926-03,G9
HTR2A,5-HT2A Antagonists?,NCGC00015004-11,F2
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,G9
NA,adrenergenic receptor antagaonist,NCGC00015121-16,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,G8
NR1I3,Constitutive Androstane Receptor Antagonist,NCGC00015205-07,D10
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,F2
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,G9
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,F2
HRH1,Histamine H1 Receptor Antagonists,NCGC00015252-13,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G8
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00015267-09,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G8
NA,antimalarial agents,NCGC00015349-06,G9
NA,antimalarial agents,NCGC00015349-06,G8
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,G9
NA,K(ATP) Channel Blockers,NCGC00015462-12,F2
NA,Calcium Channels (Voltage-Gated) alpha2/delta-1/2 Subunit Ligand,NCGC00015466-04,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,F2
HRH1,Histamine H1 Receptor Antagonists,NCGC00015580-08,F2
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G8
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G9
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,D10
JAK1,Jak inhibitor,NCGC00015610-18,G8
JAK1,Jak inhibitor,NCGC00015610-18,G9
NA,H+/K+-ATPase Inhibitor,NCGC00015615-14,F2
HRH1,Histamine H1 Receptor Antagonists,NCGC00015619-09,G9
HTR2A,5-HT2A Antagonists?,NCGC00015656-06,F2
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G8
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,F2
GRM5,mgluR5 Antagonists,NCGC00015682-02,G8
GRM5,mgluR5 Antagonists,NCGC00015682-02,G9
GRM5,mgluR5 Antagonists,NCGC00015682-02,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00015693-08,G9
NA,noradrenaline reuptake inhibitor,NCGC00015708-17,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
AR,Androgen Receptor Antagonist,NCGC00015754-15,F2
NA,Muscarinic Antagonists,NCGC00015767-09,G8
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,G9
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,F2
NA,anti-arrythmia drug,NCGC00015819-11,G8
NA,anti-arrythmia drug,NCGC00015819-11,G9
NA,anti-arrythmia drug,NCGC00015819-11,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G9
GRM1,Glutamate Release Inhibitor,NCGC00015882-09,F2
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,F2
NA,Alkaloid anitpsychotic,NCGC00015888-04,G8
NA,Alkaloid anitpsychotic,NCGC00015888-04,G9
PTGS2,Cyclooxygenase-2 Inhibitor,NCGC00015892-07,G8
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,G9
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,F2
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,G9
DRD2,Calcium Channel Blocker,NCGC00016083-13,G9
CNR1,Cannabinoid Receptor Agonist,NCGC00016210-06,F2
MMP1,MMP Inhibitor,NCGC00016246-12,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
NA,antidiabetic drug,NCGC00016543-08,G8
NA,antidiabetic drug,NCGC00016543-08,G9
HRH1,Histamine H1 Receptor Antagonists,NCGC00016710-04,F2
PPARA,PPARalpha agonist,NCGC00016794-14,G9
NA,vasodilator,NCGC00016831-04,C8
NA,antiparasitic agent,NCGC00016855-11,F2
ABCC3,ABCC3 Expression Enhancer,NCGC00016925-10,F2
NA,Antifungal Agent,NCGC00017112-11,G9
NA,Antifungal Agent,NCGC00017112-11,C8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,D10
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,G8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
NA,Calcium Channel Blocker,NCGC00018102-06,F2
NA,Treatment of Osteoporosis,NCGC00018139-08,G9
NA,Treatment of Osteoporosis,NCGC00018139-08,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G9
NA,Steroid hormone,NCGC00018176-04,G8
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,F2
PDE1,Sodium channel inhibitor,NCGC00018204-11,G8
PDE1,Sodium channel inhibitor,NCGC00018204-11,F2
NA,Antifungal Agent,NCGC00018258-09,F2
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G8
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G9
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G8
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G9
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,F2
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G8
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G9
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,C8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,D10
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,F2
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,G8
NA,Corticosteroid,NCGC00023373-04,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
ESR1,Estrogen Receptor Antagonist,NCGC00024762-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G8
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G9
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,G8
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,G9
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,D10
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,G9
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,F2
PAR1,PAR1 Antagonist,NCGC00025225-02,G8
PAR1,PAR1 Antagonist,NCGC00025225-02,G9
PAR1,PAR1 Antagonist,NCGC00025225-02,F2
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,G8
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,F2
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G8
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G9
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00025355-11,F2
ESR1,Estrogen Receptor (ER) Agonist,NCGC00090749-11,F2
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G8
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G9
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G8
NA,HIV Protease Inhibitors,NCGC00090782-07,G9
NA,HIV Protease Inhibitors,NCGC00090782-07,G8
NA,Macrolide Antibiotic,NCGC00090808-03,G9
NA,Macrolide Antibiotic,NCGC00090808-03,D10
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,G9
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00091057-06,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
ESR1,Estrogen Receptor (ER) Agonist,NCGC00091544-08,C8
RARG,RARgamma Agonist,NCGC00092284-03,D10
RARG,RARgamma Agonist,NCGC00092284-03,F2
RARG,RARgamma Agonist,NCGC00092284-03,G8
RARG,RARgamma Agonist,NCGC00092284-03,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,D10
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,F2
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G8
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
GRIN2A,NMDA Antagonist,NCGC00092329-01,F2
GRM1,mgluR1 Antagonists,NCGC00092375-02,G8
GRM1,mgluR1 Antagonists,NCGC00092375-02,G9
GRM1,mgluR1 Antagonists,NCGC00092375-02,G8
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,G9
AR,Androgen Receptor Antagonist,NCGC00093560-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,F2
HTR1A,5-HT Reuptake Inhibitor,NCGC00095109-06,G9
HTR4,5-HT4 Partial Agonists,NCGC00095192-06,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
NA,HIV Protease Inhibitors,NCGC00159461-03,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00159509-02,F2
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G8
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G9
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,F2
CALM1,Calmodulin Antagonist,NCGC00159544-02,G8
ESR1,Selective Estrogen Receptor Modulators (SERM),NCGC00160530-03,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,G8
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G8
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00162385-05,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
PPARG,PPARgamma Agonists?,NCGC00163128-07,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
NA,Macrolide Antibiotic,NCGC00163470-09,G8
SMO,Smo Receptor Antagonist,NCGC00163474-05,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
ESR1,Selective Estrogen Receptor Modulators (SERM),NCGC00164385-04,F2
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,G8
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00164559-04,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
NA,HIV Protease Inhibitors,NCGC00164576-03,G8
NA,HIV Protease Inhibitors,NCGC00164576-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,F2
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
ESR1,Estrogen Receptor Antagonist,NCGC00164789-05,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G9
AKT1,AKT 1/2 Inhibitor,NCGC00165727-02,F2
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G9
NA,cardiomyocytes differentiation initiator,NCGC00165770-03,G8
PPARA,PPARalpha Antagonist,NCGC00165799-02,G9
PPARA,PPARalpha Antagonist,NCGC00165799-02,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
FGFR,FGFR 1/3 inhibitor,NCGC00165863-02,F2
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G8
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G9
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,C8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G9
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,F2
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G9
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK5) Inhibitor,NCGC00165898-02,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G9
NA,antimalarial agents,NCGC00166281-02,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
NA,Antifungal Agent,NCGC00167430-03,G9
NA,Antifungal Agent,NCGC00167430-03,F2
NA,antimalarial agents,NCGC00167490-02,G8
NA,antimalarial agents,NCGC00167490-02,G9
NA,antimalarial agents,NCGC00167490-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00167503-02,G8
NA,Macrolide Antibiotic,NCGC00167506-03,G9
NA,Macrolide Antibiotic,NCGC00167506-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,G8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,G8
NA,Antibacterial,NCGC00167532-01,G8
IKBKB,IKK1_:_ IKK-2_:_ IKK complex inhibitor,NCGC00167767-03,D10
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
CASP3,Procaspase 3 Activator,NCGC00167785-02,G8
CASP3,Procaspase 3 Activator,NCGC00167785-02,G9
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,F2
NA,Ketolide antibiotic,NCGC00167967-01,G8
NA,Ketolide antibiotic,NCGC00167967-01,G9
ARHGEF1,GEF inhibitor,NCGC00168109-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,F2
NA,HIV Protease Inhibitors,NCGC00168773-01,G8
NA,HIV Protease Inhibitors,NCGC00168773-01,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00168781-01,C8
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,D10
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,F2
NA,antiprotozoal agent,NCGC00168785-02,D10
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,F2
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G8
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G9
HRH1,Histamine H1 Receptor Antagonists,NCGC00177979-03,C8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,F2
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,G9
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,F2
HTR3A,5-HT3 Antagonists,NCGC00179341-02,C8
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Polyether Antibiotic,NCGC00179454-04,G8
NA,Polyether Antibiotic,NCGC00179454-04,G9
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Antifungal Agent,NCGC00179596-04,G9
NA,Antifungal Agent,NCGC00179596-04,F2
NA,Antifungal Agent,NCGC00179642-04,G8
NA,Antifungal Agent,NCGC00179642-04,G9
NA,Antifungal Agent,NCGC00179642-04,G9
NA,Glucocorticoid steroid,NCGC00179649-07,F2
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,G9
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,C8
HTR1B,5-HT1B Agonist,NCGC00181786-03,D10
HTR1B,5-HT1B Agonist,NCGC00181786-03,G8
HTR1B,5-HT1B Agonist,NCGC00181786-03,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00182037-01,F2
SYK,Syk Kinase inhibitor,NCGC00182051-02,G8
SYK,Syk Kinase inhibitor,NCGC00182051-02,G9
SYK,Syk Kinase inhibitor,NCGC00182051-02,F2
CCR5,Chemokine CCR5 Antagonist,NCGC00182549-02,F2
NA,HIV Protease Inhibitors,NCGC00182552-03,G8
NA,HIV Protease Inhibitors,NCGC00182552-03,G9
GRIN2A,NMDA Antagonist,NCGC00182554-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NA,Tetracycline Antibiotic,NCGC00183044-01,G9
NA,Tetracycline Antibiotic,NCGC00183044-01,F2
NA,HIV Protease Inhibitors,NCGC00183130-01,G8
NA,HIV Protease Inhibitors,NCGC00183130-01,G9
NA,HIV Protease Inhibitors,NCGC00183130-01,F2
ABL1,Bcr-Abl Kinase Inhibitor,NCGC00183285-04,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,G8
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,F2
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,G9
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
IRAK1,IRAK Inhibitor,NCGC00186035-04,G8
GR1A1,AMPA Antagonist,NCGC00186046-02,G9
GR1A1,AMPA Antagonist,NCGC00186046-02,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
MTOR,mTOR inhibitor,NCGC00187481-04,D10
PIK3CA,PI3Kalpha_:_ beta_:_ gamma Inhibitor,NCGC00187906-01,F2
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G8
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G9
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,C8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,F2
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G9
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C8
MTOR,mTOR Inhibitor,NCGC00188346-01,D10
MTOR,mTOR Inhibitor,NCGC00188346-01,G8
MTOR,mTOR Inhibitor,NCGC00188346-01,G9
MTOR,mTOR Inhibitor,NCGC00188346-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00188380-01,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
DRD1,Dopamine D1/D2 Antagonist,NCGC00188689-01,F2
P2RY12,P2Y12 (P2T) Antagonists,NCGC00188690-02,F2
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G8
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G9
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,F2
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G8
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G9
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,F2
CERS1,multi-kinase,NCGC00188865-02,G8
CERS1,multi-kinase,NCGC00188865-02,G9
CERS1,multi-kinase,NCGC00188865-02,F2
RAC1,Rac1 inhibitor,NCGC00188866-01,G9
RAC1,Rac1 inhibitor,NCGC00188866-01,C8
MAP2K1,MEK inhibitor,NCGC00189074-01,F2
MAP2K1,MEK inhibitor,NCGC00189074-01,G8
MAP2K1,MEK inhibitor,NCGC00189074-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,G9
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,F2
BLM,BLM inhibitor,NCGC00189393-03,G8
BLM,BLM inhibitor,NCGC00189393-03,G9
BLM,BLM inhibitor,NCGC00189393-03,D10
ITK,ITK inhibitor,NCGC00229512-04,F2
ITK,ITK inhibitor,NCGC00229512-04,G8
ITK,ITK inhibitor,NCGC00229512-04,G9
ITK,ITK inhibitor,NCGC00229512-04,F2
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G8
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G9
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,C8
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,F2
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,G8
JARID2,JMJ inhibitor,NCGC00241036-02,G9
JARID2,JMJ inhibitor,NCGC00241036-02,G9
SRC,cSRC inhibitor,NCGC00241099-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00241101-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
KIT,FGFR 3 Inhibitor,NCGC00241103-04,G8
ABL1,Bcr-Abl inhibitor,NCGC00241107-03,G8
MAPK14,p38 MAPK Inhibitor,NCGC00241111-02,F2
IRAK1,IRAK Inhibitor,NCGC00241410-01,G8
IRAK1,IRAK Inhibitor,NCGC00241410-01,G9
IRAK1,IRAK Inhibitor,NCGC00241410-01,D10
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,F2
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G8
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G9
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G8
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G9
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
MTOR,mTORC1/2 inhibitor,NCGC00242484-02,F2
MAPK7,ERK inhibitor,NCGC00242487-01,G9
MAPK7,ERK inhibitor,NCGC00242487-01,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
TRIO,Triple Functional Domain Protein (TRIO) Inhibitor,NCGC00242501-01,C8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,F2
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G9
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak1/2 inhibitor,NCGC00244257-01,G9
NA,antimalarial agents,NCGC00246187-02,F2
NA,antiinfluenza drug,NCGC00246387-02,G8
NA,antiinfluenza drug,NCGC00246387-02,G9
NA,antiinfluenza drug,NCGC00246387-02,F2
NA,Perinuclear compartment (PNC) assembly inhibitor,NCGC00247785-05,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G9
SLC6A9,Glycine Transporter 1 (GlyT-1) Inhibitor,NCGC00247954-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00249390-01,C8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,G8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00250085-01,F2
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,G8
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
HTR4,5-HT4 Antagonists,NCGC00250378-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
IKBKB,IKK-beta Inhibitor,NCGC00250384-01,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,D10
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G9
PLCG1,Phospholipase C inhibitor,NCGC00250389-01,G8
HDAC1,Histone Deacetylase (HDAC) 6 Inhibitor,NCGC00250390-01,D10
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,F2
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G9
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00250400-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,G8
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00250407-01,F2
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G8
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,F2
NA,Antifungal Agent,NCGC00253713-02,G8
NA,Antifungal Agent,NCGC00253713-02,G9
NA,Antifungal Agent,NCGC00253713-02,G8
SYK,Syk Kinase inhibitor,NCGC00253909-01,G9
SYK,Syk Kinase inhibitor,NCGC00253909-01,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
IDH1,Isocitrate dehydrogenase inhibitor,NCGC00262689-01,F2
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G8
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G9
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263016-01,F2
TLR7,TLR 7_:_ 8 and 9 antagonist,NCGC00263017-01,C8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,F2
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G9
WNT5A,Wnt signaling modulator,NCGC00263085-01,D10
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,F2
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G8
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G9
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,D10
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G8
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G9
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
TTK,monopolar spindle 1 (Mps1)?kinase inhibitor,NCGC00263090-01,C8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G9
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00263094-01,D10
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,G9
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,C8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G9
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
PAR2,PAR2 Antagonist,NCGC00263107-01,G9
PAR2,PAR2 Antagonist,NCGC00263107-01,G8
PAR1,PAR1 Antagonist,NCGC00263108-01,G9
PAR1,PAR1 Antagonist,NCGC00263108-01,D10
MTOR,mTOR inhibitor,NCGC00263109-02,G8
MTOR,mTOR inhibitor,NCGC00263109-02,G8
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,G9
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,G8
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,G8
GH1,Growth Hormone Secretagogue,NCGC00263115-01,F2
PRKCB,PKC beta Inhibitor,NCGC00263119-01,F2
AR,Androgen Receptor Antagonist,NCGC00263120-01,G8
AR,Androgen Receptor Antagonist,NCGC00263120-01,G9
MDM2,HDM2/HDMX inhibitor,NCGC00263124-01,G8
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,G9
PCK1,cPEPCK inhibitor,NCGC00263130-01,F2
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,G9
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,F2
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G8
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G9
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G9
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G9
HSPA2,Heat Shock Protein 70 (hsp70) Inhibitor,NCGC00263143-01,C8
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,D10
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,C8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,F2
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G9
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,G9
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,F2
MDM2,MDM2 (hdm2) Inhibitor,NCGC00263171-01,F2
AURKA,Aurora-A Inhibitor,NCGC00263178-01,G8
AURKA,Aurora-A Inhibitor,NCGC00263178-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,G8
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263185-01,F2
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G8
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G9
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C8
TEK,Tie-2 inhibitor,NCGC00263199-02,G8
TEK,Tie-2 inhibitor,NCGC00263199-02,G9
TYK2,Tyk 2 inhibitor,NCGC00263200-01,D10
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
JAK2,Jak2 inhibitor,NCGC00263202-01,C8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G9
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G9
IKBKB,IKK-2 (IKK-beta) Inhibitor,NCGC00263213-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263214-01,C8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,D10
MTOR,mTORC1 Inhibitor,NCGC00263216-02,F2
MTOR,mTORC1 Inhibitor,NCGC00263216-02,G8
CERS1,Ceramide kinase inhibitor,NCGC00263217-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,F2
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G9
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,D10
FAS,Fatty acid synthase inhibitor,NCGC00263228-01,G8
MGLL,Monoacylglycerol lipase (MAGL) inhibitor,NCGC00263237-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,G8
FAS,FAS inhibitor,NCGC00263281-01,G9
SRD5A1,Steroid 5alpha-Reductase Inhibitors,NCGC00263522-02,G9
NA,50S Ribosomal Protein Inhibitors,NCGC00263531-03,F2
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,G9
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
NA,K(ATP) Channel Activators,NCGC00263564-02,G8
NA,K(ATP) Channel Activators,NCGC00263564-02,G9
NA,K(ATP) Channel Activators,NCGC00263564-02,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00274063-01,G9
MPL,Thrombopoietin Receptor (TpoR) Agonists,NCGC00274067-01,G9
CHEK1,Chk1 Inhibitor,NCGC00343768-01,G9
NA,lineage-specific differentiation enhancer,NCGC00344053-01,G8
NA,Calcium Channel Blocker,NCGC00344506-01,F2
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344507-02,G9
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344509-01,F2
NA,Opioid receptor antagonist,NCGC00344511-02,G8
NA,Opioid receptor antagonist,NCGC00344511-02,G9
NA,Opioid receptor antagonist,NCGC00344511-02,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,G9
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,F2
NA,DOT1L Inhibitor,NCGC00344622-02,G8
NA,DOT1L Inhibitor,NCGC00344622-02,G9
NA,DOT1L Inhibitor,NCGC00344622-02,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,G8
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,G9
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,C8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,D10
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345083-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345083-01,F2
SHH,Hedgehog antagonist,NCGC00345084-01,G9
SHH,Hedgehog antagonist,NCGC00345084-01,F2
JAK2,Jak2 inhibitor,NCGC00345461-02,G8
JAK2,Jak2 inhibitor,NCGC00345461-02,G9
JAK2,Jak2 inhibitor,NCGC00345461-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,F2
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,G9
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,F2
NAE1,NEDD8-Activating Enzyme (NAE) Inhibitors,NCGC00345794-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00345795-01,F2
JAK2,Jak2 inhibitor,NCGC00345798-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
HDAC6,Histone Deacetylase (HDAC) 6 Inhibitor,NCGC00345802-01,C8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,F2
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345805-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,F2
LIMK1,LIMK Inhibitor,NCGC00345825-01,G8
LIMK1,LIMK Inhibitor,NCGC00345825-01,F2
MAPK8,JNK Inhibitor,NCGC00345826-01,G8
MAPK8,JNK Inhibitor,NCGC00345826-01,C8
SRC,cSRC inhibitor,NCGC00345829-01,F2
SRC,cSRC inhibitor,NCGC00345829-01,F2
ROCK2,ROCK II Inhibitor,NCGC00345833-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345837-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345837-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345838-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345838-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345849-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345849-01,C8
MAPK8,JNK Inhibitor,NCGC00345850-01,F2
MAPK8,JNK Inhibitor,NCGC00345850-01,G8
MAPK8,JNK Inhibitor,NCGC00345850-01,G9
MAPK8,JNK Inhibitor,NCGC00345850-01,C8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345851-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
JAK2,Jak2 inhibitor,NCGC00345854-01,G8
JAK2,Jak2 inhibitor,NCGC00345854-01,F2
BTK,BTK Inhibitor,NCGC00345857-01,G8
BTK,BTK Inhibitor,NCGC00345857-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G9
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,F2
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,G9
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,G9
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,C8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G9
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
PDE5A,Phosphodiesterase III/Va (PDE) inhibitor,NCGC00346449-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
FGFR,FGFR Inhibitor,NCGC00346459-01,D10
FGFR,FGFR Inhibitor,NCGC00346459-01,G8
FGFR,FGFR Inhibitor,NCGC00346459-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
NA,Bacterial Efflux Pump Inhibitors,NCGC00346474-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346483-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G8
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G9
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,D10
HDAC1,HDAC Inhibitor,NCGC00346486-01,F2
HDAC1,HDAC Inhibitor,NCGC00346486-01,G8
HDAC1,HDAC Inhibitor,NCGC00346486-01,G9
HDAC1,HDAC Inhibitor,NCGC00346486-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,G9
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00346511-01,F2
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G8
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G9
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,F2
AURKA,Aurora A Inhibitor,NCGC00346525-01,G8
NA,Sodium channel inhibitor,NCGC00346529-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
NA,HCV NS5A Inhibitors,NCGC00346533-01,G8
NA,HCV NS5A Inhibitors,NCGC00346533-01,G9
NA,HCV NS5A Inhibitors,NCGC00346533-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346536-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346536-01,D10
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,C8
NA,Antifungal Agent,NCGC00346538-01,F2
NA,Antifungal Agent,NCGC00346538-01,G9
NA,Antifungal Agent,NCGC00346538-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,F2
MAP2K5,Mek 5 Inhibitor,NCGC00346543-01,F2
MAP2K5,Mek 5 Inhibitor,NCGC00346544-01,C8
CFTR,CFTR Channel Modulator,NCGC00346550-01,D10
CFTR,CFTR Channel Modulator,NCGC00346550-01,F2
CFTR,CFTR Channel Modulator,NCGC00346550-01,F2
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,G9
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,G9
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,F2
TUBB,Tubulin polymerization inhibitor,NCGC00346580-01,F2
JAK2,Jak2/3 Inhibitor,NCGC00346581-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
NA,Alkaloid,NCGC00346589-01,C8
PfATP6,antimalarial agents,NCGC00346590-01,G8
PfATP6,antimalarial agents,NCGC00346590-01,G9
PfATP6,antimalarial agents,NCGC00346590-01,F2
NA,5-HT Release Inhibitor,NCGC00346591-01,G8
NA,5-HT Release Inhibitor,NCGC00346591-01,G9
NA,5-HT Release Inhibitor,NCGC00346591-01,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G9
GRM2,mgluR2/3 Agonists,NCGC00346612-01,C8
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,D10
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,F2
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
GCK,Glucokinase activator,NCGC00346628-01,G8
GCK,Glucokinase activator,NCGC00346628-01,F2
NA,HIV Integrase Inhibitors,NCGC00346629-01,G9
NA,HIV Integrase Inhibitors,NCGC00346629-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
MTOR,mTOR inhibitor,NCGC00346634-01,D10
MTOR,mTOR inhibitor,NCGC00346634-01,G8
MTOR,mTOR inhibitor,NCGC00346634-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,F2
SRC,Src Kinase Inhibitors,NCGC00346644-01,G8
SRC,Src Kinase Inhibitors,NCGC00346644-01,G9
SRC,Src Kinase Inhibitors,NCGC00346644-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346649-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346649-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
DPP4,Dipeptidyl Peptidase IV (CD26; DPP-IV; DP-IV) Inhibitor,NCGC00346655-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346659-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C8
CDK1,CDK1/2/4/5 Inhibitor,NCGC00346673-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G8
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G9
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G8
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G9
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,D10
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,F2
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,G8
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
FLT1,VEGFR-1 (Flt-1) Inhibitors,NCGC00346695-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,G9
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,C8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,F2
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G9
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
BACE1,beta-Secretase Inhibitor,NCGC00346719-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G9
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G8
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346740-01,F2
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,G8
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
ABCBA,P-Glycoprotein (MDR-1; ABCB1) Inhibitors,NCGC00346894-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G8
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G9
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G8
PIM1,Pim 1/2/3 Kinase Inhibitor,NCGC00346935-01,F2
NA,Thrombin Inhibitors,NCGC00346938-01,G8
NA,Thrombin Inhibitors,NCGC00346938-01,G9
NA,Thrombin Inhibitors,NCGC00346938-01,C8
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,D10
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,G9
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,F2
ITK,ITK inhibitor,NCGC00346941-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346955-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346955-01,D10
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,F2
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346958-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346959-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346959-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G9
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,F2
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G8
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G9
NA,M18 Aspartyl Aminopeptidase Inhibitor,NCGC00347063-01,F2
NA,p97 ATPase Inhibitor,NCGC00347064-01,G8
NA,p97 ATPase Inhibitor,NCGC00347065-01,F2
NA,p97 ATPase Inhibitor,NCGC00347066-01,G8
NA,p97 ATPase Inhibitor,NCGC00347066-01,G9
NA,p97 ATPase Inhibitor,NCGC00347066-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,EZH2 Methyltransferase Inhibitor,NCGC00347286-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347909-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00347910-01,G8
NA,Mutant IDH1 Inhibitor,NCGC00347934-01,F2
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,G9
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,D10
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,G9
WNT5A,Wnt Signaling Inhibitor,NCGC00347949-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,F2
SHH,Hedgehog agonist,NCGC00347954-01,G8
SHH,Hedgehog agonist,NCGC00347954-01,G9
SHH,Hedgehog agonist,NCGC00347954-01,F2
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G8
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G9
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,G8
JAK2,Jak2 inhibitor,NCGC00014911-01,C5
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C5
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C5
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00016786-14,C5
NA,antiparasitic agent,NCGC00016855-11,C8
NA,antiparasitic agent,NCGC00016855-11,F2
TOP1,DNA Topoisomerase I Inhibitors,NCGC00016994-16,C5
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,D10
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,G8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C5
NA,Antifungal Agent,NCGC00017338-05,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C5
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
GSK3B,Glycogen Synthase Kinase 3 beta (GSK-3beta; tau Protein Kinase I) Inhibitor,NCGC00017363-10,C5
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,D10
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,F2
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,G8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C5
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,Antineoplastic Antibiotics,NCGC00024246-13,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
DNMT1,DNA Methyltransferase (DNMT) Inhibitor,NCGC00090851-09,C5
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C5
RARG,RARgamma Agonist,NCGC00092284-03,C8
RARG,RARgamma Agonist,NCGC00092284-03,D10
RARG,RARgamma Agonist,NCGC00092284-03,F2
RARG,RARgamma Agonist,NCGC00092284-03,G8
RARG,RARgamma Agonist,NCGC00092284-03,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C5
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C5
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00159459-02,C5
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PRKCA,PKC Activator,NCGC00162381-03,C5
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
NA,Antineoplastic Antibiotics,NCGC00162440-01,F2
NA,Antineoplastic Antibiotics,NCGC00162440-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C5
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,DNA Polymerase Inhibitors,NCGC00164553-03,F2
NA,DNA Polymerase Inhibitors,NCGC00164553-03,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,C5
PfATP6,antimalarial agents,NCGC00164600-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C5
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C5
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,F2
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C5
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C5
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G9
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,F2
TYMS,thymidylate synthase inhibitor,NCGC00166323-03,C5
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00167431-02,C5
NA,antimalarial agents,NCGC00167496-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00167503-02,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00167503-02,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C5
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C8
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,D10
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,F2
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C5
NA,Polyether Antibiotic,NCGC00179454-04,C8
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Polyether Antibiotic,NCGC00179454-04,G8
NA,Polyether Antibiotic,NCGC00179454-04,G9
NA,Polyether Antibiotic,NCGC00179454-04,C5
HTR1B,5-HT1B Agonist,NCGC00181786-03,C8
HTR1B,5-HT1B Agonist,NCGC00181786-03,D10
HTR1B,5-HT1B Agonist,NCGC00181786-03,G8
HTR1B,5-HT1B Agonist,NCGC00181786-03,G9
HTR1B,5-HT1B Agonist,NCGC00181786-03,C5
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C5
NA,Calcium Channel Blocker,NCGC00183837-01,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C5
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,F2
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G9
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C5
MTOR,mTOR Inhibitor,NCGC00188346-01,C8
MTOR,mTOR Inhibitor,NCGC00188346-01,D10
MTOR,mTOR Inhibitor,NCGC00188346-01,G8
MTOR,mTOR Inhibitor,NCGC00188346-01,G9
MTOR,mTOR Inhibitor,NCGC00188346-01,C5
ITK,ITK inhibitor,NCGC00188382-04,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
ITK,ITK inhibitor,NCGC00188382-04,C5
MAP2K1,MEK inhibitor,NCGC00189074-01,C8
MAP2K1,MEK inhibitor,NCGC00189074-01,F2
MAP2K1,MEK inhibitor,NCGC00189074-01,G8
MAP2K1,MEK inhibitor,NCGC00189074-01,C5
MAP2K1,MEK inhibitor,NCGC00189075-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
TYMS,thymidylate synthase inhibitor,NCGC00229704-01,C5
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,C8
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,F2
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,C5
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C5
SRC,cSRC inhibitor,NCGC00242490-02,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
SRC,cSRC inhibitor,NCGC00242490-02,C5
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,F2
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G9
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C5
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C5
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00242596-01,C5
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C5
JAK1,Jak1/2 inhibitor,NCGC00244257-01,C8
JAK1,Jak1/2 inhibitor,NCGC00244257-01,G9
JAK1,Jak1/2 inhibitor,NCGC00244257-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247878-01,C5
JAK2,Jak2 inhibitor,NCGC00249346-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
JAK2,Jak2 inhibitor,NCGC00249346-02,C5
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,C8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,G8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C5
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C5
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C5
SMO,Smo Receptor Antagonist,NCGC00250382-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
SMO,Smo Receptor Antagonist,NCGC00250382-01,C5
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C5
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,D10
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G9
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C5
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,F2
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,G8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,C5
JAK2,Jak2 inhibitor,NCGC00262608-02,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
JAK2,Jak2 inhibitor,NCGC00262608-02,C5
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,F2
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G9
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C5
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G9
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C5
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G9
ATM,ATM Kinase Inhibitor,NCGC00263099-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263117-02,C5
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,C8
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,D10
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,C5
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,F2
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G9
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C5
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,F2
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G9
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263177-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,MEK inhibitor,NCGC00263187-01,F2
MAP2K1,MEK inhibitor,NCGC00263187-01,G8
MAP2K1,MEK inhibitor,NCGC00263187-01,G9
MAP2K1,MEK inhibitor,NCGC00263187-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C5
TEK,Tie-2 inhibitor,NCGC00263199-02,C8
TEK,Tie-2 inhibitor,NCGC00263199-02,G8
TEK,Tie-2 inhibitor,NCGC00263199-02,G9
TEK,Tie-2 inhibitor,NCGC00263199-02,C5
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G9
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C5
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,D10
MTOR,mTORC1 Inhibitor,NCGC00263216-02,F2
MTOR,mTORC1 Inhibitor,NCGC00263216-02,G8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C5
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,F2
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G9
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C5
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C5
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C5
PfATP6,artemesinin analogue,NCGC00263270-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,C5
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C5
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C5
ITK,ITK inhibitor,NCGC00344990-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,D10
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C5
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C5
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C5
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C8
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,F2
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,G9
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C5
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C5
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,F2
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,C5
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C5
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C5
SRC,cSRC inhibitor,NCGC00345829-01,C8
SRC,cSRC inhibitor,NCGC00345829-01,F2
SRC,cSRC inhibitor,NCGC00345829-01,C5
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C5
JAK2,Jak2 inhibitor,NCGC00345846-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,C5
MAPK8,JNK Inhibitor,NCGC00345850-01,C8
MAPK8,JNK Inhibitor,NCGC00345850-01,F2
MAPK8,JNK Inhibitor,NCGC00345850-01,G8
MAPK8,JNK Inhibitor,NCGC00345850-01,G9
MAPK8,JNK Inhibitor,NCGC00345850-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345851-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C5
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G9
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C5
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
MAP2K1,Mek Inhibitor,NCGC00346455-01,C5
FGFR,FGFR Inhibitor,NCGC00346459-01,C8
FGFR,FGFR Inhibitor,NCGC00346459-01,D10
FGFR,FGFR Inhibitor,NCGC00346459-01,G8
FGFR,FGFR Inhibitor,NCGC00346459-01,C5
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,C8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C5
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C5
NA,Polyether Antibiotic,NCGC00346524-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C5
NA,Antifungal Agent,NCGC00346538-01,C8
NA,Antifungal Agent,NCGC00346538-01,F2
NA,Antifungal Agent,NCGC00346538-01,G9
NA,Antifungal Agent,NCGC00346538-01,C5
CFTR,CFTR Channel Modulator,NCGC00346550-01,C8
CFTR,CFTR Channel Modulator,NCGC00346550-01,D10
CFTR,CFTR Channel Modulator,NCGC00346550-01,F2
CFTR,CFTR Channel Modulator,NCGC00346550-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
MAP2K1,MEK inhibitor,NCGC00346567-01,F2
MAP2K1,MEK inhibitor,NCGC00346567-01,G8
MAP2K1,MEK inhibitor,NCGC00346567-01,G9
MAP2K1,MEK inhibitor,NCGC00346567-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C5
PfATP6,antimalarial agents,NCGC00346590-01,C8
PfATP6,antimalarial agents,NCGC00346590-01,G8
PfATP6,antimalarial agents,NCGC00346590-01,G9
PfATP6,antimalarial agents,NCGC00346590-01,C5
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C8
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,D10
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,F2
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C5
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
CHEK1,Chk1 Inhibitor,NCGC00346626-01,F2
CHEK1,Chk1 Inhibitor,NCGC00346626-01,G8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,C5
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,C5
MTOR,mTOR inhibitor,NCGC00346634-01,C8
MTOR,mTOR inhibitor,NCGC00346634-01,D10
MTOR,mTOR inhibitor,NCGC00346634-01,G8
MTOR,mTOR inhibitor,NCGC00346634-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346659-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C5
CDK1,CDK1/2/4/5 Inhibitor,NCGC00346673-01,C8
CDK1,CDK1/2/4/5 Inhibitor,NCGC00346673-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G9
SCD,Stearoyl-CoA Desaturase Inhibitors,NCGC00346680-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C5
NA,photosensitizer,NCGC00346712-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,C5
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,F2
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G9
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C5
CDK1,CDK1/2/4/6,NCGC00346827-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
CDK1,CDK1/2/4/6,NCGC00346827-01,C5
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C5
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C8
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,D10
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,G9
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
FLT3,FLT3,NCGC00346964-01,G8
FLT3,FLT3,NCGC00346964-01,C5
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C5
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C5
NA,Oct4 Activator,NCGC00347953-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,C5
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,D10
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,F2
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,G9
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,C5
JAK1,Jak inhibitor,NCGC00015610-18,D10
JAK1,Jak inhibitor,NCGC00015610-18,G8
JAK1,Jak inhibitor,NCGC00015610-18,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00015693-08,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00015693-08,C5
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C5
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C5
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C5
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,D10
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,G8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C5
NA,Antifungal Agent,NCGC00017338-05,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C5
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C5
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,D10
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,F2
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,G8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
NA,Pyrimidine Antagonists,NCGC00023722-07,C5
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,Antineoplastic Antibiotics,NCGC00024246-13,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C5
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,D10
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,G9
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,C5
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,D10
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,G9
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,C5
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C5
RARG,RARgamma Agonist,NCGC00092284-03,C8
RARG,RARgamma Agonist,NCGC00092284-03,D10
RARG,RARgamma Agonist,NCGC00092284-03,F2
RARG,RARgamma Agonist,NCGC00092284-03,G8
RARG,RARgamma Agonist,NCGC00092284-03,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,C5
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,D10
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,F2
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G8
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C5
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C5
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,C5
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PRKCA,PKC Activator,NCGC00162381-03,D10
PRKCA,PKC Activator,NCGC00162381-03,C5
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
NA,Antineoplastic Antibiotics,NCGC00162440-01,D10
NA,Antineoplastic Antibiotics,NCGC00162440-01,F2
NA,Antineoplastic Antibiotics,NCGC00162440-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
POLR2A,Inhibition of RNA polymerase II?mediated transcription,NCGC00163411-05,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C5
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,DNA Polymerase Inhibitors,NCGC00164553-03,D10
NA,DNA Polymerase Inhibitors,NCGC00164553-03,F2
NA,DNA Polymerase Inhibitors,NCGC00164553-03,C5
PfATP6,antimalarial agents,NCGC00164600-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C5
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C5
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165869-03,C5
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G9
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C5
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,D10
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,F2
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G9
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,C5
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C5
NA,antimalarial agents,NCGC00167496-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,D10
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,G8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,C5
CASP3,Procaspase 3 Activator,NCGC00167785-02,D10
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
CASP3,Procaspase 3 Activator,NCGC00167785-02,G8
CASP3,Procaspase 3 Activator,NCGC00167785-02,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00167982-02,C5
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C8
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,D10
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,F2
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C5
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,D10
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,F2
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G8
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G9
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C5
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,D10
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,F2
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,G9
ABL1,Bcr-Abl inhibitor,NCGC00181129-05,C5
HTR1B,5-HT1B Agonist,NCGC00181786-03,C8
HTR1B,5-HT1B Agonist,NCGC00181786-03,D10
HTR1B,5-HT1B Agonist,NCGC00181786-03,G8
HTR1B,5-HT1B Agonist,NCGC00181786-03,G9
VDR,Vitamin D Analog,NCGC00182058-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00182713-01,C5
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C5
NA,Calcium Channel Blocker,NCGC00183837-01,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C5
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C5
PIK3CA,PI3Kalpha_:_ beta_:_ gamma Inhibitor,NCGC00187906-01,D10
PIK3CA,PI3Kalpha_:_ beta_:_ gamma Inhibitor,NCGC00187906-01,C5
MTOR,mTOR Inhibitor,NCGC00188346-01,C8
MTOR,mTOR Inhibitor,NCGC00188346-01,D10
MTOR,mTOR Inhibitor,NCGC00188346-01,G8
MTOR,mTOR Inhibitor,NCGC00188346-01,G9
MTOR,mTOR Inhibitor,NCGC00188346-01,C5
ITK,ITK inhibitor,NCGC00188382-04,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
ITK,ITK inhibitor,NCGC00188382-04,C5
MAP2K1,MEK inhibitor,NCGC00189075-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,C5
ITK,ITK inhibitor,NCGC00229512-04,D10
ITK,ITK inhibitor,NCGC00229512-04,F2
ITK,ITK inhibitor,NCGC00229512-04,G8
ITK,ITK inhibitor,NCGC00229512-04,G9
ITK,ITK inhibitor,NCGC00229512-04,C5
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C5
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,D10
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,F2
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G8
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G9
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C5
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,D10
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G8
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G9
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,C5
SRC,cSRC inhibitor,NCGC00242490-02,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
SRC,cSRC inhibitor,NCGC00242490-02,C5
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C5
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
BIRC5,Survivin inhibitor,NCGC00242514-01,C5
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C5
JAK2,Jak2 inhibitor,NCGC00249346-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
JAK2,Jak2 inhibitor,NCGC00249346-02,C5
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C5
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C5
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C5
SMO,Smo Receptor Antagonist,NCGC00250382-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
SMO,Smo Receptor Antagonist,NCGC00250382-01,C5
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C5
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,D10
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G9
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C5
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,F2
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G9
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,G9
MTOR,mTOR inhibitor,NCGC00250398-01,C5
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,D10
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,F2
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,G8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,C5
JAK2,Jak2 inhibitor,NCGC00262608-02,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
JAK2,Jak2 inhibitor,NCGC00262608-02,C5
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,D10
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,F2
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G8
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G9
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,C5
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,D10
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G8
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G9
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,C5
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,D10
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,G9
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00263103-01,C5
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,C5
MTOR,mTOR inhibitor,NCGC00263109-02,D10
MTOR,mTOR inhibitor,NCGC00263109-02,G8
MTOR,mTOR inhibitor,NCGC00263109-02,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,G8
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263117-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263117-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,C5
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,C8
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,D10
MAPK8,JNK 1/2/3 Inhibitor,NCGC00263146-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C5
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,C8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,D10
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,F2
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G9
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C5
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,D10
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,G9
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263177-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263177-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,MEK inhibitor,NCGC00263187-01,D10
MAP2K1,MEK inhibitor,NCGC00263187-01,F2
MAP2K1,MEK inhibitor,NCGC00263187-01,G8
MAP2K1,MEK inhibitor,NCGC00263187-01,G9
MAP2K1,MEK inhibitor,NCGC00263187-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,D10
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,C5
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,D10
MTOR,mTORC1 Inhibitor,NCGC00263216-02,F2
MTOR,mTORC1 Inhibitor,NCGC00263216-02,G8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00263223-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00263223-01,C5
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C5
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C5
PfATP6,artemesinin analogue,NCGC00263270-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,C5
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C5
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C5
ITK,ITK inhibitor,NCGC00344990-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344999-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,D10
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C5
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C5
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C5
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,C5
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C5
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345837-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345837-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345837-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345838-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345838-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345838-01,C5
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C5
JAK2,Jak2 inhibitor,NCGC00345846-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345849-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345849-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345849-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345851-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346437-01,F2
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G9
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,C5
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
PIK3CA,PI3K alpha/delta Inhibitor,NCGC00346457-01,C5
FGFR,FGFR Inhibitor,NCGC00346459-01,C8
FGFR,FGFR Inhibitor,NCGC00346459-01,D10
FGFR,FGFR Inhibitor,NCGC00346459-01,G8
FGFR,FGFR Inhibitor,NCGC00346459-01,C5
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346484-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346484-01,C5
HDAC1,HDAC Inhibitor,NCGC00346486-01,D10
HDAC1,HDAC Inhibitor,NCGC00346486-01,F2
HDAC1,HDAC Inhibitor,NCGC00346486-01,G8
HDAC1,HDAC Inhibitor,NCGC00346486-01,G9
HDAC1,HDAC Inhibitor,NCGC00346486-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C5
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C5
NA,Polyether Antibiotic,NCGC00346524-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346536-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346536-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346536-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,D10
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,C5
CFTR,CFTR Channel Modulator,NCGC00346550-01,C8
CFTR,CFTR Channel Modulator,NCGC00346550-01,D10
CFTR,CFTR Channel Modulator,NCGC00346550-01,F2
CFTR,CFTR Channel Modulator,NCGC00346550-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
MAP2K1,MEK inhibitor,NCGC00346567-01,D10
MAP2K1,MEK inhibitor,NCGC00346567-01,F2
MAP2K1,MEK inhibitor,NCGC00346567-01,G8
MAP2K1,MEK inhibitor,NCGC00346567-01,G9
MAP2K1,MEK inhibitor,NCGC00346567-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C5
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C8
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,D10
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,F2
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C5
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,D10
CHEK1,Chk1 Inhibitor,NCGC00346626-01,F2
CHEK1,Chk1 Inhibitor,NCGC00346626-01,G8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,C5
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,C5
MTOR,mTOR inhibitor,NCGC00346634-01,C8
MTOR,mTOR inhibitor,NCGC00346634-01,D10
MTOR,mTOR inhibitor,NCGC00346634-01,G8
MTOR,mTOR inhibitor,NCGC00346634-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346649-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346649-01,G8
PIK3CA,PI3Kalpha_:_ beta_:_ gamma Inhibitor,NCGC00346650-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,D10
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346659-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C5
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,D10
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,F2
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,G8
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C5
NA,photosensitizer,NCGC00346712-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,G8
PIK3CA,PI3K alpha Inhibitor,NCGC00346717-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,C5
CDK1,CDK1/2/4/6,NCGC00346827-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
CDK1,CDK1/2/4/6,NCGC00346827-01,C5
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C5
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C8
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,D10
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,G9
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C5
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,D10
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,F2
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,G8
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,C5
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C5
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C5
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,D10
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,G9
NA,Mutant p53 Activator,NCGC00347952-01,C5
NA,Oct4 Activator,NCGC00347953-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,C5
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C5
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,F2
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G8
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G9
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,C5
NA,Calcium Channel Blocker,NCGC00014926-03,F2
NA,Calcium Channel Blocker,NCGC00014926-03,G8
NA,Calcium Channel Blocker,NCGC00014926-03,G9
NA,Calcium Channel Blocker,NCGC00014926-03,C5
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,F2
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,G9
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,C5
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,G8
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,C5
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,D10
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,F2
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,G9
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,C5
HRH1,Histamine H1 Receptor Antagonists,NCGC00015252-13,F2
HRH1,Histamine H1 Receptor Antagonists,NCGC00015252-13,C5
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G8
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G9
DRD2,Dopamine D2 Antagonist,NCGC00015436-09,C5
NA,Calcium Channels (Voltage-Gated) alpha2/delta-1/2 Subunit Ligand,NCGC00015466-04,F2
NA,Calcium Channels (Voltage-Gated) alpha2/delta-1/2 Subunit Ligand,NCGC00015466-04,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,C5
DRD2,Dopamine D2 Antagonist,NCGC00015500-10,F2
DRD2,Dopamine D2 Antagonist,NCGC00015500-10,C5
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,F2
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G8
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G9
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,C5
HRH1,Histamine H1 Receptor Antagonists,NCGC00015619-09,F2
HRH1,Histamine H1 Receptor Antagonists,NCGC00015619-09,C5
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,F2
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G8
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,C5
GRM5,mgluR5 Antagonists,NCGC00015682-02,F2
GRM5,mgluR5 Antagonists,NCGC00015682-02,G8
GRM5,mgluR5 Antagonists,NCGC00015682-02,G9
GRM5,mgluR5 Antagonists,NCGC00015682-02,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,C5
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C5
NA,Muscarinic Antagonists,NCGC00015767-09,F2
PGR,Progestogen hormone,NCGC00015785-04,C5
NA,anti-arrythmia drug,NCGC00015819-11,F2
NA,anti-arrythmia drug,NCGC00015819-11,G8
NA,anti-arrythmia drug,NCGC00015819-11,G9
NA,anti-arrythmia drug,NCGC00015819-11,C5
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C5
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,C5
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,C5
NA,Alkaloid anitpsychotic,NCGC00015888-04,F2
NA,Alkaloid anitpsychotic,NCGC00015888-04,G8
NA,Alkaloid anitpsychotic,NCGC00015888-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00016017-07,C5
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,F2
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,G9
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,C5
MMP1,MMP Inhibitor,NCGC00016246-12,F2
NA,Steroid,NCGC00016447-02,C5
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C5
NA,antidiabetic drug,NCGC00016543-08,F2
NA,antidiabetic drug,NCGC00016543-08,G8
NA,antidiabetic drug,NCGC00016543-08,G9
NA,antidiabetic drug,NCGC00016543-08,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00016740-19,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00016740-19,C5
NA,antiparasitic agent,NCGC00016855-11,C8
NA,antiparasitic agent,NCGC00016855-11,F2
NA,antiparasitic agent,NCGC00016855-11,C5
NA,Antifungal Agent,NCGC00017112-11,F2
NA,Antifungal Agent,NCGC00017112-11,G9
NA,Antifungal Agent,NCGC00017112-11,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C5
NA,Antifungal Agent,NCGC00017338-05,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C5
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C5
NA,Treatment of Osteoporosis,NCGC00018139-08,F2
NA,Treatment of Osteoporosis,NCGC00018139-08,G9
NA,Treatment of Osteoporosis,NCGC00018139-08,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,C5
PDE1,Sodium channel inhibitor,NCGC00018204-11,F2
PDE1,Sodium channel inhibitor,NCGC00018204-11,G8
PDE1,Sodium channel inhibitor,NCGC00018204-11,C5
NA,Antifungal Agent,NCGC00018258-09,F2
NA,Antifungal Agent,NCGC00018258-09,C5
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,F2
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G8
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G9
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,C5
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,F2
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G8
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G9
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,C5
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,F2
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G8
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G9
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,C5
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,D10
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,F2
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,G8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
NA,Pyrimidine Antagonists,NCGC00023722-07,F2
NA,Pyrimidine Antagonists,NCGC00023722-07,C5
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,antiprotozoal agent,NCGC00024379-04,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C5
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,F2
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G8
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G9
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,C8
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00025060-16,F2
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00025060-16,C5
PAR1,PAR1 Antagonist,NCGC00025225-02,F2
PAR1,PAR1 Antagonist,NCGC00025225-02,G8
PAR1,PAR1 Antagonist,NCGC00025225-02,G9
PAR1,PAR1 Antagonist,NCGC00025225-02,C5
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,F2
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,G8
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,C5
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,F2
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G8
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G9
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,C5
ESR1,Estrogen Receptor (ER) Agonist,NCGC00090749-11,F2
RARB,RARbeta/gamma Agonist,NCGC00090752-08,C5
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,F2
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G8
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G9
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,C5
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,D10
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,G9
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,C5
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C5
RARG,RARgamma Agonist,NCGC00092284-03,C8
RARG,RARgamma Agonist,NCGC00092284-03,D10
RARG,RARgamma Agonist,NCGC00092284-03,F2
RARG,RARgamma Agonist,NCGC00092284-03,G8
RARG,RARgamma Agonist,NCGC00092284-03,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,C5
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,D10
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,F2
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G8
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,C5
GRM1,mgluR1 Antagonists,NCGC00092375-02,F2
GRM1,mgluR1 Antagonists,NCGC00092375-02,G8
GRM1,mgluR1 Antagonists,NCGC00092375-02,G9
GRM1,mgluR1 Antagonists,NCGC00092375-02,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
NA,Purine Antagonist,NCGC00094792-06,C5
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C5
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C5
NA,K(ATP) Channel Blockers,NCGC00095107-10,F2
NA,Fungal Squalene Monooxygenase Inhibitor,NCGC00159346-05,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C5
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,F2
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G8
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G9
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,C5
CALM1,Calmodulin Antagonist,NCGC00159544-02,F2
CALM1,Calmodulin Antagonist,NCGC00159544-02,G8
AURKA,Aurora-A/B Inhibitor,NCGC00159574-02,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G9
VDR,Vitamin D Analog,NCGC00161327-05,C5
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,G8
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00161419-03,C5
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C5
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,F2
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G8
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G9
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,C5
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
NA,Antineoplastic Antibiotics,NCGC00162440-01,D10
NA,Antineoplastic Antibiotics,NCGC00162440-01,F2
NA,Antineoplastic Antibiotics,NCGC00162440-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
NA,Antimigraine drugs,NCGC00163169-02,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
PRKCA,PKC inhibitor,NCGC00163505-03,C5
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,Antineoplastic Antibiotics,NCGC00163548-02,C5
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,F2
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,G8
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,C8
NA,DNA Polymerase Inhibitors,NCGC00164553-03,D10
NA,DNA Polymerase Inhibitors,NCGC00164553-03,F2
NA,DNA Polymerase Inhibitors,NCGC00164553-03,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00164574-05,C5
NA,HIV Protease Inhibitors,NCGC00164576-03,F2
NA,HIV Protease Inhibitors,NCGC00164576-03,G8
NA,HIV Protease Inhibitors,NCGC00164576-03,C5
PfATP6,antimalarial agents,NCGC00164600-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C5
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C5
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,F2
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,F2
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,C5
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C5
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,F2
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G8
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G9
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,C5
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,D10
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,F2
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G9
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G9
TUBB,Tubulin polymerization inhibitor,NCGC00166035-02,C8
TYMS,thymidylate synthase inhibitor,NCGC00166323-03,F2
TYMS,thymidylate synthase inhibitor,NCGC00166323-03,C5
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C5
NA,Antifungal Agent,NCGC00167430-03,F2
NA,Antifungal Agent,NCGC00167430-03,G9
NA,Antifungal Agent,NCGC00167430-03,C5
NA,antimalarial agents,NCGC00167490-02,F2
NA,antimalarial agents,NCGC00167490-02,G8
NA,antimalarial agents,NCGC00167490-02,G9
NA,antimalarial agents,NCGC00167490-02,C5
NA,antimalarial agents,NCGC00167496-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,D10
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,G8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,C5
CASP3,Procaspase 3 Activator,NCGC00167785-02,D10
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
CASP3,Procaspase 3 Activator,NCGC00167785-02,G8
CASP3,Procaspase 3 Activator,NCGC00167785-02,G9
CASP3,Procaspase 3 Activator,NCGC00167785-02,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,C5
NA,Ketolide antibiotic,NCGC00167967-01,F2
NA,Ketolide antibiotic,NCGC00167967-01,G8
NA,Ketolide antibiotic,NCGC00167967-01,G9
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00168110-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,C5
NA,HIV Protease Inhibitors,NCGC00168773-01,F2
NA,HIV Protease Inhibitors,NCGC00168773-01,G8
NA,HIV Protease Inhibitors,NCGC00168773-01,G9
NA,HIV Protease Inhibitors,NCGC00168773-01,C5
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C8
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,D10
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,F2
RRM2,ribonucleotide reductase inhibitor,NCGC00168784-01,C5
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,D10
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,F2
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G8
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G9
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C5
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,D10
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,F2
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,G9
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,C5
NA,antimalarial agents,NCGC00179250-04,F2
NA,antimalarial agents,NCGC00179250-04,C5
NA,Polyether Antibiotic,NCGC00179454-04,C8
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Polyether Antibiotic,NCGC00179454-04,G8
NA,Polyether Antibiotic,NCGC00179454-04,G9
NA,Polyether Antibiotic,NCGC00179454-04,C5
NA,Antifungal Agent,NCGC00179596-04,F2
NA,Antifungal Agent,NCGC00179596-04,G9
NA,Antifungal Agent,NCGC00179596-04,C5
NA,Antifungal Agent,NCGC00179642-04,F2
NA,Antifungal Agent,NCGC00179642-04,G8
NA,Antifungal Agent,NCGC00179642-04,G9
NA,Antifungal Agent,NCGC00179642-04,G8
PNP,Purine-Nucleoside Phosphorylase Inhibitors,NCGC00181336-03,C5
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,F2
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,G9
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,C5
SYK,Syk Kinase inhibitor,NCGC00182051-02,F2
SYK,Syk Kinase inhibitor,NCGC00182051-02,G8
SYK,Syk Kinase inhibitor,NCGC00182051-02,G9
SYK,Syk Kinase inhibitor,NCGC00182051-02,C5
SIRT1,Histone Deacetylase/SIRT1 Activator,NCGC00182052-03,F2
SIRT1,Histone Deacetylase/SIRT1 Activator,NCGC00182052-03,C5
NA,HIV Protease Inhibitors,NCGC00182552-03,F2
NA,HIV Protease Inhibitors,NCGC00182552-03,G8
NA,HIV Protease Inhibitors,NCGC00182552-03,G9
NA,HIV Protease Inhibitors,NCGC00182552-03,C5
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C5
NA,HIV Protease Inhibitors,NCGC00183130-01,F2
NA,HIV Protease Inhibitors,NCGC00183130-01,G8
NA,HIV Protease Inhibitors,NCGC00183130-01,G9
NA,HIV Protease Inhibitors,NCGC00183130-01,C5
ABL1,Bcr-Abl Kinase Inhibitor,NCGC00183285-04,F2
ABL1,Bcr-Abl Kinase Inhibitor,NCGC00183285-04,C5
NA,Calcium Channel Blocker,NCGC00183837-01,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G9
APE1,APE1 inhibitor,NCGC00185090-03,C5
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,G8
PIK3CG,PI3K gamma Inhibitor,NCGC00186009-03,C5
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,F2
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,G9
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C5
IRAK1,IRAK Inhibitor,NCGC00186035-04,F2
IRAK1,IRAK Inhibitor,NCGC00186035-04,C5
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C5
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,F2
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G8
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G9
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,C5
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,F2
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G9
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00188380-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00188380-01,C5
ITK,ITK inhibitor,NCGC00188382-04,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
ITK,ITK inhibitor,NCGC00188382-04,C5
P2RY12,P2Y12 (P2T) Antagonists,NCGC00188690-02,F2
P2RY12,P2Y12 (P2T) Antagonists,NCGC00188690-02,C5
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,F2
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G8
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G9
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,C5
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,F2
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G8
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G9
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,C5
CERS1,multi-kinase,NCGC00188865-02,F2
CERS1,multi-kinase,NCGC00188865-02,G8
CERS1,multi-kinase,NCGC00188865-02,G9
CERS1,multi-kinase,NCGC00188865-02,C5
RAC1,Rac1 inhibitor,NCGC00188866-01,F2
RAC1,Rac1 inhibitor,NCGC00188866-01,G9
MAP2K1,Mek1/2 inibitor,NCGC00189073-02,C5
MAP2K1,MEK inhibitor,NCGC00189074-01,C8
MAP2K1,MEK inhibitor,NCGC00189074-01,F2
MAP2K1,MEK inhibitor,NCGC00189074-01,G8
MAP2K1,MEK inhibitor,NCGC00189074-01,C5
MAP2K1,MEK inhibitor,NCGC00189075-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,C5
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,G9
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,C5
BLM,BLM inhibitor,NCGC00189393-03,F2
BLM,BLM inhibitor,NCGC00189393-03,G8
BLM,BLM inhibitor,NCGC00189393-03,G9
BLM,BLM inhibitor,NCGC00189393-03,C5
ITK,ITK inhibitor,NCGC00229512-04,D10
ITK,ITK inhibitor,NCGC00229512-04,F2
ITK,ITK inhibitor,NCGC00229512-04,G8
ITK,ITK inhibitor,NCGC00229512-04,G9
ITK,ITK inhibitor,NCGC00229512-04,C8
TYMS,thymidylate synthase inhibitor,NCGC00229704-01,F2
TYMS,thymidylate synthase inhibitor,NCGC00229704-01,C5
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,F2
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G8
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G9
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,C5
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,C8
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,F2
ALK,Anaplastic Lymphoma Kinase (ALK) Inhibitor,NCGC00238453-01,C5
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C5
KIT,FGFR 3 Inhibitor,NCGC00241103-04,F2
CLK1,Clk Inhibitor,NCGC00241342-02,C5
IRAK1,IRAK Inhibitor,NCGC00241410-01,F2
IRAK1,IRAK Inhibitor,NCGC00241410-01,G8
IRAK1,IRAK Inhibitor,NCGC00241410-01,G9
IRAK1,IRAK Inhibitor,NCGC00241410-01,C5
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,D10
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,F2
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G8
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G9
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00242217-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C5
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,D10
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G8
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G9
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,C5
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00242482-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00242482-01,C5
MAPK7,ERK inhibitor,NCGC00242487-01,F2
MAPK7,ERK inhibitor,NCGC00242487-01,G9
MAPK7,ERK inhibitor,NCGC00242487-01,C5
SRC,cSRC inhibitor,NCGC00242490-02,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
SRC,cSRC inhibitor,NCGC00242490-02,C5
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,F2
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G9
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C5
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C5
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00242596-01,F2
DHFR,Dihydrofolate Reductase (DHFR) Inhibitors,NCGC00242596-01,C5
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C5
NA,antiinfluenza drug,NCGC00246387-02,F2
NA,antiinfluenza drug,NCGC00246387-02,G8
NA,antiinfluenza drug,NCGC00246387-02,G9
NA,antiinfluenza drug,NCGC00246387-02,C5
NA,Perinuclear compartment (PNC) assembly inhibitor,NCGC00247785-05,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247877-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247878-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247878-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,C5
JAK2,Jak2 inhibitor,NCGC00249346-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
JAK2,Jak2 inhibitor,NCGC00249346-02,C5
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,C8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,G8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,G8
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,G9
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C5
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C5
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,F2
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,G8
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C5
HTR4,5-HT4 Antagonists,NCGC00250378-01,F2
HTR4,5-HT4 Antagonists,NCGC00250378-01,C5
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C5
SMO,Smo Receptor Antagonist,NCGC00250382-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
ERN1,IRE1alpha/XBP-1 inhibitor,NCGC00250383-01,C5
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C5
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,F2
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G9
TNKS,TNKS1/TNKS2 Inhibitor,NCGC00250397-01,C5
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C5
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,G8
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,C5
BRAF,Raf kinase B/C inhibitor,NCGC00250407-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00250407-01,C8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,D10
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,F2
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,G8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,C5
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,F2
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G8
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00253438-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C5
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,C5
NA,Antifungal Agent,NCGC00253713-02,F2
NA,Antifungal Agent,NCGC00253713-02,G8
NA,Antifungal Agent,NCGC00253713-02,G9
NA,Antifungal Agent,NCGC00253713-02,G8
MAPK14,p38 MAPK Inhibitor,NCGC00262195-02,C5
JAK2,Jak2 inhibitor,NCGC00262608-02,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
JAK2,Jak2 inhibitor,NCGC00262608-02,C5
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,F2
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G8
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G9
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263016-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263016-01,C5
TLR7,TLR 7_:_ 8 and 9 antagonist,NCGC00263017-01,F2
TLR7,TLR 7_:_ 8 and 9 antagonist,NCGC00263017-01,C5
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,F2
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G9
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C5
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,D10
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,F2
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G8
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G9
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263087-01,C5
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,D10
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G8
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G9
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,C5
TTK,monopolar spindle 1 (Mps1)?kinase inhibitor,NCGC00263090-01,F2
TTK,monopolar spindle 1 (Mps1)?kinase inhibitor,NCGC00263090-01,C5
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G9
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C5
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00263094-01,F2
PRKCA,PKC inhibitor,NCGC00263095-01,C5
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G9
ATM,ATM Kinase Inhibitor,NCGC00263099-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263100-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263100-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,C5
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,G8
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,C5
PRKCB,PKC beta Inhibitor,NCGC00263119-01,F2
PRKCB,PKC beta Inhibitor,NCGC00263119-01,C5
AR,Androgen Receptor Antagonist,NCGC00263120-01,F2
AR,Androgen Receptor Antagonist,NCGC00263120-01,G8
AR,Androgen Receptor Antagonist,NCGC00263120-01,G9
AR,Androgen Receptor Antagonist,NCGC00263120-01,C5
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,F2
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,G9
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,C5
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,F2
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G8
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G9
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,C5
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,F2
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G9
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C5
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,C8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,D10
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,F2
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G9
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,C5
MDM2,MDM2 (hdm2) Inhibitor,NCGC00263171-01,F2
KIF11,Kinesin-Like Spindle Protein Inhibitor,NCGC00263174-01,C5
AURKA,Aurora-A Inhibitor,NCGC00263178-01,F2
AURKA,Aurora-A Inhibitor,NCGC00263178-01,G8
AURKA,Aurora-A Inhibitor,NCGC00263178-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C5
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,F2
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,G8
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,C5
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,F2
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G8
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G9
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,C8
MAP2K1,MEK inhibitor,NCGC00263187-01,D10
MAP2K1,MEK inhibitor,NCGC00263187-01,F2
MAP2K1,MEK inhibitor,NCGC00263187-01,G8
MAP2K1,MEK inhibitor,NCGC00263187-01,G9
MAP2K1,MEK inhibitor,NCGC00263187-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,D10
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,C5
JAK2,Jak2 inhibitor,NCGC00263202-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00263203-02,C5
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G9
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G9
ADH7,Alcohol dehydrogenase 7 inhibitor,NCGC00263211-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263214-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263214-01,C5
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,D10
MTOR,mTORC1 Inhibitor,NCGC00263216-02,F2
MTOR,mTORC1 Inhibitor,NCGC00263216-02,G8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C5
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,F2
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G9
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C5
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C5
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C5
PfATP6,artemesinin analogue,NCGC00263270-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,C5
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,F2
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,G9
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,C5
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C5
NA,K(ATP) Channel Activators,NCGC00263564-02,F2
NA,K(ATP) Channel Activators,NCGC00263564-02,G8
NA,K(ATP) Channel Activators,NCGC00263564-02,G9
NA,K(ATP) Channel Activators,NCGC00263564-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
NA,Renal cell growth inhibition,NCGC00344081-02,C5
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344507-02,F2
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344507-02,C5
NA,Opioid receptor antagonist,NCGC00344511-02,F2
NA,Opioid receptor antagonist,NCGC00344511-02,G8
NA,Opioid receptor antagonist,NCGC00344511-02,G9
NA,Opioid receptor antagonist,NCGC00344511-02,C5
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,G9
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,C5
NA,DOT1L Inhibitor,NCGC00344622-02,F2
NA,DOT1L Inhibitor,NCGC00344622-02,G8
NA,DOT1L Inhibitor,NCGC00344622-02,G9
NA,DOT1L Inhibitor,NCGC00344622-02,C5
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C5
ITK,ITK inhibitor,NCGC00344990-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344999-01,F2
ITK,ITK inhibitor,NCGC00344999-01,C5
SHH,Hedgehog antagonist,NCGC00345084-01,F2
SHH,Hedgehog antagonist,NCGC00345084-01,G9
SHH,Hedgehog antagonist,NCGC00345084-01,C5
JAK2,Jak2 inhibitor,NCGC00345461-02,F2
JAK2,Jak2 inhibitor,NCGC00345461-02,G8
JAK2,Jak2 inhibitor,NCGC00345461-02,G9
JAK2,Jak2 inhibitor,NCGC00345461-02,C5
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C5
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C5
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C8
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,F2
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,G9
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,C5
NAE1,NEDD8-Activating Enzyme (NAE) Inhibitors,NCGC00345794-01,F2
NAE1,NEDD8-Activating Enzyme (NAE) Inhibitors,NCGC00345794-01,C5
JAK2,Jak2 inhibitor,NCGC00345798-01,F2
JAK2,Jak2 inhibitor,NCGC00345798-01,C5
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C5
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,F2
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00345804-01,C5
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C5
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C5
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,C5
LIMK1,LIMK Inhibitor,NCGC00345825-01,F2
LIMK1,LIMK Inhibitor,NCGC00345825-01,G8
LIMK1,LIMK Inhibitor,NCGC00345825-01,C5
MAPK8,JNK Inhibitor,NCGC00345826-01,F2
MAPK8,JNK Inhibitor,NCGC00345826-01,G8
MAPK8,JNK Inhibitor,NCGC00345826-01,C5
SRC,cSRC inhibitor,NCGC00345829-01,C8
SRC,cSRC inhibitor,NCGC00345829-01,F2
SRC,cSRC inhibitor,NCGC00345829-01,C5
ROCK2,ROCK II Inhibitor,NCGC00345833-01,F2
ROCK2,ROCK II Inhibitor,NCGC00345833-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G8
AKT1,AKT Inhibitor,NCGC00345840-01,G9
TYK2,Tyk 2 inhibitor,NCGC00345844-01,C5
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C5
JAK2,Jak2 inhibitor,NCGC00345846-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,C5
MAPK8,JNK Inhibitor,NCGC00345850-01,C8
MAPK8,JNK Inhibitor,NCGC00345850-01,F2
MAPK8,JNK Inhibitor,NCGC00345850-01,G8
MAPK8,JNK Inhibitor,NCGC00345850-01,G9
MAPK8,JNK Inhibitor,NCGC00345850-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00345853-01,C5
JAK2,Jak2 inhibitor,NCGC00345854-01,F2
JAK2,Jak2 inhibitor,NCGC00345854-01,G8
JAK2,Jak2 inhibitor,NCGC00345854-01,C5
BTK,BTK Inhibitor,NCGC00345857-01,F2
BTK,BTK Inhibitor,NCGC00345857-01,G8
BTK,BTK Inhibitor,NCGC00345857-01,C5
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G9
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,C5
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,F2
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,G9
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C5
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,G9
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,C5
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G9
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346448-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346448-01,D10
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,F2
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G9
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,C5
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
IGFR1,IGF-1R Inhibitor,NCGC00346460-02,C5
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346483-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346483-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346484-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346484-01,C5
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,F2
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G8
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G9
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,C5
HDAC1,HDAC Inhibitor,NCGC00346486-01,D10
HDAC1,HDAC Inhibitor,NCGC00346486-01,F2
HDAC1,HDAC Inhibitor,NCGC00346486-01,G8
HDAC1,HDAC Inhibitor,NCGC00346486-01,G9
HDAC1,HDAC Inhibitor,NCGC00346486-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
AURKA,Aurora-A/B Inhibitor,NCGC00346493-01,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,C8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00346496-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C5
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,F2
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,G9
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C5
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,F2
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G8
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G9
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,C5
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C5
NA,Polyether Antibiotic,NCGC00346524-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,C5
AURKA,Aurora A Inhibitor,NCGC00346525-01,F2
AURKA,Aurora A Inhibitor,NCGC00346525-01,G8
AURKA,Aurora A Inhibitor,NCGC00346525-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C5
NA,HCV NS5A Inhibitors,NCGC00346533-01,F2
NA,HCV NS5A Inhibitors,NCGC00346533-01,G8
NA,HCV NS5A Inhibitors,NCGC00346533-01,G9
NA,HCV NS5A Inhibitors,NCGC00346533-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346536-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346536-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346536-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,D10
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,C5
NA,Antifungal Agent,NCGC00346538-01,C8
NA,Antifungal Agent,NCGC00346538-01,F2
NA,Antifungal Agent,NCGC00346538-01,G9
NA,Antifungal Agent,NCGC00346538-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,C5
MAP2K5,Mek 5 Inhibitor,NCGC00346543-01,F2
MAP2K5,Mek 5 Inhibitor,NCGC00346543-01,C5
MAP2K5,Mek 5 Inhibitor,NCGC00346544-01,F2
AKT1,Akt1/2/3 Inhibitor,NCGC00346549-01,C5
CFTR,CFTR Channel Modulator,NCGC00346550-01,C8
CFTR,CFTR Channel Modulator,NCGC00346550-01,D10
CFTR,CFTR Channel Modulator,NCGC00346550-01,F2
CFTR,CFTR Channel Modulator,NCGC00346550-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G9
CDK7,CDK7 Inhibitor,NCGC00346553-01,C5
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,F2
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,G9
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
MAP2K1,MEK inhibitor,NCGC00346567-01,D10
MAP2K1,MEK inhibitor,NCGC00346567-01,F2
MAP2K1,MEK inhibitor,NCGC00346567-01,G8
MAP2K1,MEK inhibitor,NCGC00346567-01,G9
MAP2K1,MEK inhibitor,NCGC00346567-01,C5
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,F2
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,G9
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,C5
KIF11,Kinesin-Like Spindle Protein Inhibitor,NCGC00346571-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00346577-01,C5
JAK2,Jak2/3 Inhibitor,NCGC00346581-01,F2
JAK2,Jak2/3 Inhibitor,NCGC00346581-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C5
NA,Alkaloid,NCGC00346589-01,F2
NA,Alkaloid,NCGC00346589-01,C5
NA,5-HT Release Inhibitor,NCGC00346591-01,F2
NA,5-HT Release Inhibitor,NCGC00346591-01,G8
NA,5-HT Release Inhibitor,NCGC00346591-01,G9
NA,5-HT Release Inhibitor,NCGC00346591-01,C5
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C8
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,D10
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,F2
PDGFRA,PDGFR Inhibitor,NCGC00346619-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,C5
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,D10
CHEK1,Chk1 Inhibitor,NCGC00346626-01,F2
CHEK1,Chk1 Inhibitor,NCGC00346626-01,G8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,C5
GCK,Glucokinase activator,NCGC00346628-01,F2
GCK,Glucokinase activator,NCGC00346628-01,G8
GCK,Glucokinase activator,NCGC00346628-01,C5
NA,HIV Integrase Inhibitors,NCGC00346629-01,F2
NA,HIV Integrase Inhibitors,NCGC00346629-01,G9
NA,HIV Integrase Inhibitors,NCGC00346629-01,C5
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,C5
SRC,Src Kinase Inhibitors,NCGC00346644-01,F2
SRC,Src Kinase Inhibitors,NCGC00346644-01,G8
SRC,Src Kinase Inhibitors,NCGC00346644-01,G9
AURKB,Aurora-B/C Inhibitor,NCGC00346648-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,D10
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,C5
DPP4,Dipeptidyl Peptidase IV (CD26; DPP-IV; DP-IV) Inhibitor,NCGC00346655-01,F2
DPP4,Dipeptidyl Peptidase IV (CD26; DPP-IV; DP-IV) Inhibitor,NCGC00346655-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C5
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G8
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G9
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C5
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,F2
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G8
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G9
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,C5
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,D10
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,F2
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,G8
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C5
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,G9
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,C5
NA,photosensitizer,NCGC00346712-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,C5
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,F2
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G9
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
AR,Androgen Receptor Agonist,NCGC00346733-01,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G9
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,C5
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,F2
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,G8
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,C5
CDK1,CDK1/2/4/6,NCGC00346827-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
OPRL1,ORL1 (OP4_:_ NOP) Agonists,NCGC00346896-01,C5
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C5
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,F2
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G8
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G9
TUBB,Tubulin polymerization inhibitor,NCGC00346937-01,C5
NA,Thrombin Inhibitors,NCGC00346938-01,F2
NA,Thrombin Inhibitors,NCGC00346938-01,G8
NA,Thrombin Inhibitors,NCGC00346938-01,G9
NA,Thrombin Inhibitors,NCGC00346938-01,C5
ITK,ITK inhibitor,NCGC00346941-01,F2
ITK,ITK inhibitor,NCGC00346941-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,C5
LCK,Lck Kinase Inhibitors,NCGC00346955-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346955-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346955-01,C5
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,D10
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,F2
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,G8
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,C5
LCK,Lck Kinase Inhibitors,NCGC00346959-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346959-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346959-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G9
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,C8
FLT3,FLT3,NCGC00346964-01,F2
FLT3,FLT3,NCGC00346964-01,G8
FLT4,FLT4,NCGC00346965-01,C5
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,F2
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G8
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G9
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,C5
NA,p97 ATPase Inhibitor,NCGC00347064-01,F2
NA,p97 ATPase Inhibitor,NCGC00347064-01,G8
NA,p97 ATPase Inhibitor,NCGC00347064-01,C5
NA,p97 ATPase Inhibitor,NCGC00347066-01,F2
NA,p97 ATPase Inhibitor,NCGC00347066-01,G8
NA,p97 ATPase Inhibitor,NCGC00347066-01,G9
NA,p97 ATPase Inhibitor,NCGC00347066-01,C5
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,C5
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
TNK2,ACK1/TNK2 Inhibitor,NCGC00347279-01,C5
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C5
NA,EZH2 Methyltransferase Inhibitor,NCGC00347286-01,F2
NA,EZH2 Methyltransferase Inhibitor,NCGC00347286-01,G8
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,G9
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00347910-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00347910-01,C5
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,F2
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,G9
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,C5
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,D10
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,C5
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,C5
NA,Oct4 Activator,NCGC00347953-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,C5
SHH,Hedgehog agonist,NCGC00347954-01,F2
SHH,Hedgehog agonist,NCGC00347954-01,G8
SHH,Hedgehog agonist,NCGC00347954-01,G9
SHH,Hedgehog agonist,NCGC00347954-01,C5
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,F2
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G8
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G9
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,C5
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,C5
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,F2
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G8
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G9
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,C5
NA,Calcium Channel Blocker,NCGC00014926-03,F2
NA,Calcium Channel Blocker,NCGC00014926-03,G8
NA,Calcium Channel Blocker,NCGC00014926-03,G9
NA,Calcium Channel Blocker,NCGC00014926-03,G9
CYP2C9,Cyp2C9 Inhibitor,NCGC00015049-18,C5
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,G8
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00015122-09,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00015233-04,C5
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G8
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,C5
NA,antimalarial agents,NCGC00015349-06,G8
NA,antimalarial agents,NCGC00015349-06,G9
NA,antimalarial agents,NCGC00015349-06,C5
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,G8
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,G9
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,C5
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,F2
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G8
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G9
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,C5
JAK1,Jak inhibitor,NCGC00015610-18,D10
JAK1,Jak inhibitor,NCGC00015610-18,G8
JAK1,Jak inhibitor,NCGC00015610-18,C5
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,F2
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G8
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,C5
GRM5,mgluR5 Antagonists,NCGC00015682-02,F2
GRM5,mgluR5 Antagonists,NCGC00015682-02,G8
GRM5,mgluR5 Antagonists,NCGC00015682-02,G9
GRM5,mgluR5 Antagonists,NCGC00015682-02,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,C5
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C5
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,G8
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,G9
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,C5
NA,anti-arrythmia drug,NCGC00015819-11,F2
NA,anti-arrythmia drug,NCGC00015819-11,G8
NA,anti-arrythmia drug,NCGC00015819-11,G9
NA,anti-arrythmia drug,NCGC00015819-11,C5
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C5
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,C5
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,C5
NA,Alkaloid anitpsychotic,NCGC00015888-04,F2
NA,Alkaloid anitpsychotic,NCGC00015888-04,G8
NA,Alkaloid anitpsychotic,NCGC00015888-04,G9
NA,Alkaloid anitpsychotic,NCGC00015888-04,C5
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,G8
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,G9
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,C5
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C5
NA,antidiabetic drug,NCGC00016543-08,F2
NA,antidiabetic drug,NCGC00016543-08,G8
NA,antidiabetic drug,NCGC00016543-08,G9
AKR1B1,Aldose Reductase Inhibitor,NCGC00017245-12,C5
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,D10
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,G8
GBF1,Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitors,NCGC00017254-02,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C5
NA,Antifungal Agent,NCGC00017338-05,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C5
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,C5
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,G8
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,C5
PDE1,Sodium channel inhibitor,NCGC00018204-11,F2
PDE1,Sodium channel inhibitor,NCGC00018204-11,G8
PDE1,Sodium channel inhibitor,NCGC00018204-11,C5
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,F2
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G8
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G9
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,C5
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,F2
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G8
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G9
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,C5
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,F2
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G8
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G9
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,C5
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,D10
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,F2
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,G8
ADA,Adenosine Deaminase Inhibitor,NCGC00022567-08,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C5
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,Antineoplastic Antibiotics,NCGC00024246-13,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C5
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,F2
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G8
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G9
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00025029-05,C5
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,G8
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,G9
BRAF,Raf Kinase Inhibitors,NCGC00025109-01,C5
PAR1,PAR1 Antagonist,NCGC00025225-02,F2
PAR1,PAR1 Antagonist,NCGC00025225-02,G8
PAR1,PAR1 Antagonist,NCGC00025225-02,G9
PAR1,PAR1 Antagonist,NCGC00025225-02,C5
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,F2
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,G8
LTA4H,Leukotriene A4 Hydrolase Inhibitor,NCGC00025323-01,C5
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,F2
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G8
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G9
MAPK14,p38 MAPK Inhibitor,NCGC00025329-02,C5
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,F2
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G8
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G9
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,C5
NA,HIV Protease Inhibitors,NCGC00090782-07,G8
NA,HIV Protease Inhibitors,NCGC00090782-07,G9
NA,HIV Protease Inhibitors,NCGC00090782-07,C5
NA,Macrolide Antibiotic,NCGC00090808-03,G8
NA,Macrolide Antibiotic,NCGC00090808-03,G9
NA,Macrolide Antibiotic,NCGC00090808-03,C5
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C5
RARG,RARgamma Agonist,NCGC00092284-03,C8
RARG,RARgamma Agonist,NCGC00092284-03,D10
RARG,RARgamma Agonist,NCGC00092284-03,F2
RARG,RARgamma Agonist,NCGC00092284-03,G8
RARG,RARgamma Agonist,NCGC00092284-03,G9
CDC25,Cell Division Cycle CDC25 Phosphatase Inhibitor,NCGC00092289-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,C5
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,D10
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,F2
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G8
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,C5
GRM1,mgluR1 Antagonists,NCGC00092375-02,F2
GRM1,mgluR1 Antagonists,NCGC00092375-02,G8
GRM1,mgluR1 Antagonists,NCGC00092375-02,G9
GRM1,mgluR1 Antagonists,NCGC00092375-02,C5
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,G8
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,G9
NA,immunosuppressant,NCGC00093704-11,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C5
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C5
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C5
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,G9
GABRA1,GABAA Receptor Modulator,NCGC00095694-05,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C5
NA,HIV Protease Inhibitors,NCGC00159461-03,G8
NA,HIV Protease Inhibitors,NCGC00159461-03,G9
NA,HIV Protease Inhibitors,NCGC00159461-03,C5
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,F2
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G8
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G9
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,C5
CALM1,Calmodulin Antagonist,NCGC00159544-02,F2
CALM1,Calmodulin Antagonist,NCGC00159544-02,G8
CALM1,Calmodulin Antagonist,NCGC00159544-02,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,C5
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,G8
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00161418-02,C5
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C5
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,F2
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G8
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G9
MAPK14,p38 MAPK Inhibitor,NCGC00162142-03,C5
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C5
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C5
NA,Macrolide Antibiotic,NCGC00163470-09,G8
NA,Macrolide Antibiotic,NCGC00163470-09,C5
SMO,Smo Receptor Antagonist,NCGC00163474-05,G8
SMO,Smo Receptor Antagonist,NCGC00163474-05,C5
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,sesquiterpene natural product,NCGC00163620-02,C5
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,F2
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,G8
CYSLTR1,Leukotriene CysLT1 (LTD4) Antagonist,NCGC00164547-06,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00164566-02,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00164574-05,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00164574-05,C5
NA,HIV Protease Inhibitors,NCGC00164576-03,F2
NA,HIV Protease Inhibitors,NCGC00164576-03,G8
NA,HIV Protease Inhibitors,NCGC00164576-03,C5
PfATP6,antimalarial agents,NCGC00164600-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C5
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C5
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,F2
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,F2
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,C5
PPARA,PPARalpha Antagonist,NCGC00165799-02,G8
PPARA,PPARalpha Antagonist,NCGC00165799-02,G9
PPARA,PPARalpha Antagonist,NCGC00165799-02,C5
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165869-03,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165869-03,C5
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,F2
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G8
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G9
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,C5
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G9
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C5
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,D10
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,F2
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G9
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,C5
TGBR1,TGF-bR1 (ALK5) Inhibitor,NCGC00165898-02,G8
TGBR1,TGF-bR1 (ALK5) Inhibitor,NCGC00165898-02,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,C5
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C5
NA,antimalarial agents,NCGC00167490-02,F2
NA,antimalarial agents,NCGC00167490-02,G8
NA,antimalarial agents,NCGC00167490-02,G9
NA,antimalarial agents,NCGC00167490-02,C5
NA,antimalarial agents,NCGC00167496-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C5
NA,Macrolide Antibiotic,NCGC00167506-03,G8
NA,Macrolide Antibiotic,NCGC00167506-03,G9
NA,Macrolide Antibiotic,NCGC00167506-03,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C5
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,D10
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,F2
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,G8
EGFR,EGFR (HER1; erbB1) Inhibitor,NCGC00167513-03,C5
NA,Antibacterial,NCGC00167532-01,G8
NA,Antibacterial,NCGC00167532-01,C5
IKBKB,IKK1_:_ IKK-2_:_ IKK complex inhibitor,NCGC00167767-03,G8
IKBKB,IKK1_:_ IKK-2_:_ IKK complex inhibitor,NCGC00167767-03,C5
CASP3,Procaspase 3 Activator,NCGC00167785-02,D10
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
CASP3,Procaspase 3 Activator,NCGC00167785-02,G8
CASP3,Procaspase 3 Activator,NCGC00167785-02,G9
CASP3,Procaspase 3 Activator,NCGC00167785-02,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,C5
NA,Ketolide antibiotic,NCGC00167967-01,F2
NA,Ketolide antibiotic,NCGC00167967-01,G8
NA,Ketolide antibiotic,NCGC00167967-01,G9
PIK3CA,PI3K inhibitor,NCGC00168114-03,C5
NA,HIV Protease Inhibitors,NCGC00168773-01,F2
NA,HIV Protease Inhibitors,NCGC00168773-01,G8
NA,HIV Protease Inhibitors,NCGC00168773-01,G9
NA,HIV Protease Inhibitors,NCGC00168773-01,C5
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,D10
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,F2
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G8
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G9
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C5
NA,Polyether Antibiotic,NCGC00179454-04,C8
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Polyether Antibiotic,NCGC00179454-04,G8
NA,Polyether Antibiotic,NCGC00179454-04,G9
NA,Polyether Antibiotic,NCGC00179454-04,C5
NA,Antifungal Agent,NCGC00179642-04,F2
NA,Antifungal Agent,NCGC00179642-04,G8
NA,Antifungal Agent,NCGC00179642-04,G9
NA,Antifungal Agent,NCGC00179642-04,F2
PNP,Purine-Nucleoside Phosphorylase Inhibitors,NCGC00181336-03,G8
VEGFA,VEGFR-1_:_2_:_3 Inhibitor,NCGC00181350-02,G9
COMT,catechol-O-methyltransferase (COMT),NCGC00181767-01,C5
HTR1B,5-HT1B Agonist,NCGC00181786-03,C8
HTR1B,5-HT1B Agonist,NCGC00181786-03,D10
HTR1B,5-HT1B Agonist,NCGC00181786-03,G8
HTR1B,5-HT1B Agonist,NCGC00181786-03,G9
HTR1B,5-HT1B Agonist,NCGC00181786-03,C5
SYK,Syk Kinase inhibitor,NCGC00182051-02,F2
SYK,Syk Kinase inhibitor,NCGC00182051-02,G8
SYK,Syk Kinase inhibitor,NCGC00182051-02,G9
SYK,Syk Kinase inhibitor,NCGC00182051-02,C5
NA,HIV Protease Inhibitors,NCGC00182552-03,F2
NA,HIV Protease Inhibitors,NCGC00182552-03,G8
NA,HIV Protease Inhibitors,NCGC00182552-03,G9
NA,HIV Protease Inhibitors,NCGC00182552-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00182713-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00182713-01,C5
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C5
NA,Tetracycline Antibiotic,NCGC00183044-01,G8
NA,Tetracycline Antibiotic,NCGC00183044-01,G9
NA,Tetracycline Antibiotic,NCGC00183044-01,C5
NA,HIV Protease Inhibitors,NCGC00183130-01,F2
NA,HIV Protease Inhibitors,NCGC00183130-01,G8
NA,HIV Protease Inhibitors,NCGC00183130-01,G9
NA,HIV Protease Inhibitors,NCGC00183130-01,C5
NA,Calcium Channel Blocker,NCGC00183837-01,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,C5
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,G8
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00185850-02,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C5
GR1A1,AMPA Antagonist,NCGC00186046-02,G8
GR1A1,AMPA Antagonist,NCGC00186046-02,G9
GR1A1,AMPA Antagonist,NCGC00186046-02,C5
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C5
MTOR,mTOR inhibitor,NCGC00187481-04,G8
MTOR,mTOR inhibitor,NCGC00187481-04,C5
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,F2
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G8
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G9
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,C5
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,F2
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G9
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C5
MTOR,mTOR Inhibitor,NCGC00188346-01,C8
MTOR,mTOR Inhibitor,NCGC00188346-01,D10
MTOR,mTOR Inhibitor,NCGC00188346-01,G8
MTOR,mTOR Inhibitor,NCGC00188346-01,G9
MTOR,mTOR Inhibitor,NCGC00188346-01,C5
ITK,ITK inhibitor,NCGC00188382-04,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
ITK,ITK inhibitor,NCGC00188382-04,C5
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,F2
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G8
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G9
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,C5
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,F2
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G8
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G9
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,C5
CERS1,multi-kinase,NCGC00188865-02,F2
CERS1,multi-kinase,NCGC00188865-02,G8
CERS1,multi-kinase,NCGC00188865-02,G9
CERS1,multi-kinase,NCGC00188865-02,C5
MAP2K1,MEK inhibitor,NCGC00189074-01,C8
MAP2K1,MEK inhibitor,NCGC00189074-01,F2
MAP2K1,MEK inhibitor,NCGC00189074-01,G8
MAP2K1,MEK inhibitor,NCGC00189074-01,C5
MAP2K1,MEK inhibitor,NCGC00189075-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,C5
BLM,BLM inhibitor,NCGC00189393-03,F2
BLM,BLM inhibitor,NCGC00189393-03,G8
BLM,BLM inhibitor,NCGC00189393-03,G9
BLM,BLM inhibitor,NCGC00189393-03,C5
ITK,ITK inhibitor,NCGC00229512-04,D10
ITK,ITK inhibitor,NCGC00229512-04,F2
ITK,ITK inhibitor,NCGC00229512-04,G8
ITK,ITK inhibitor,NCGC00229512-04,G9
ITK,ITK inhibitor,NCGC00229512-04,C5
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,F2
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G8
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G9
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,C5
JARID2,JMJ inhibitor,NCGC00241036-02,G8
JARID2,JMJ inhibitor,NCGC00241036-02,G9
JARID2,JMJ inhibitor,NCGC00241036-02,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00241101-02,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00241101-02,C5
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C5
ABL1,Bcr-Abl inhibitor,NCGC00241107-03,G8
ABL1,Bcr-Abl inhibitor,NCGC00241107-03,C5
MAPK14,p38 MAPK Inhibitor,NCGC00241111-02,G8
MAPK14,p38 MAPK Inhibitor,NCGC00241112-01,C5
IRAK1,IRAK Inhibitor,NCGC00241410-01,F2
IRAK1,IRAK Inhibitor,NCGC00241410-01,G8
IRAK1,IRAK Inhibitor,NCGC00241410-01,G9
IRAK1,IRAK Inhibitor,NCGC00241410-01,C5
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,D10
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,F2
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G8
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G9
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C5
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,D10
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G8
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G9
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,C5
SRC,cSRC inhibitor,NCGC00242490-02,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
SRC,cSRC inhibitor,NCGC00242490-02,C5
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,F2
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G9
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242505-01,C5
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C5
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
TGBR1,TGF-bR1 (ALK5) and TGFbR2 inhibitor,NCGC00242598-03,C5
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C5
NA,antiinfluenza drug,NCGC00246387-02,F2
NA,antiinfluenza drug,NCGC00246387-02,G8
NA,antiinfluenza drug,NCGC00246387-02,G9
NA,antiinfluenza drug,NCGC00246387-02,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,C5
JAK2,Jak2 inhibitor,NCGC00249346-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
JAK2,Jak2 inhibitor,NCGC00249346-02,C5
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,C8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,F2
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,G8
BRAF,Raf kinase B/C inhibitor,NCGC00249391-01,F2
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,G8
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,G9
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C5
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C5
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,F2
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,G8
IGFR1,IGF-1R Inhibitors,NCGC00250375-02,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C5
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
NTRK1,Tropomyosin Related Kinases (Trk) inhibitor,NCGC00250381-02,C5
SMO,Smo Receptor Antagonist,NCGC00250382-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
SMO,Smo Receptor Antagonist,NCGC00250382-01,C5
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C5
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,D10
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G9
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C5
HDAC1,Histone Deacetylase (HDAC) 6 Inhibitor,NCGC00250390-01,G8
HDAC1,Histone Deacetylase (HDAC) 6 Inhibitor,NCGC00250390-01,C5
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,F2
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G9
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,G8
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,G9
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00250400-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00250400-01,C5
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
MTOR,mTORC1/2 Inhibitor,NCGC00250405-01,C5
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,G8
COX10,Farnesyltransferase Inhibitor,NCGC00250406-01,C8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,D10
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,F2
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,G8
PIK3CA,PI3Kalpha/beta/delta/gamma Inhibitor,NCGC00250408-01,C5
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,F2
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G8
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C5
NA,Antifungal Agent,NCGC00253713-02,F2
NA,Antifungal Agent,NCGC00253713-02,G8
NA,Antifungal Agent,NCGC00253713-02,G9
NA,Antifungal Agent,NCGC00253713-02,C5
SYK,Syk Kinase inhibitor,NCGC00253909-01,G8
SYK,Syk Kinase inhibitor,NCGC00253909-01,G9
SYK,Syk Kinase inhibitor,NCGC00253909-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00262195-02,G8
MAPK14,p38 MAPK Inhibitor,NCGC00262195-02,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00262604-01,C5
JAK2,Jak2 inhibitor,NCGC00262608-02,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
JAK2,Jak2 inhibitor,NCGC00262608-02,C5
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,F2
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G8
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G9
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263016-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263016-01,C5
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,F2
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G9
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C5
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,D10
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,F2
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G8
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G9
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,C5
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,D10
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G8
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G9
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,C5
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G9
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C5
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G9
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,C5
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,C5
PAR2,PAR2 Antagonist,NCGC00263107-01,G8
PAR2,PAR2 Antagonist,NCGC00263107-01,G9
PAR2,PAR2 Antagonist,NCGC00263107-01,C5
PAR1,PAR1 Antagonist,NCGC00263108-01,G8
PAR1,PAR1 Antagonist,NCGC00263108-01,G9
PAR1,PAR1 Antagonist,NCGC00263108-01,C5
MTOR,mTOR inhibitor,NCGC00263109-02,D10
MTOR,mTOR inhibitor,NCGC00263109-02,G8
MTOR,mTOR inhibitor,NCGC00263109-02,C5
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,G8
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,G9
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,C5
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,D10
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,F2
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,G8
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00263112-01,C5
SLC6A9,Glycine Transporter 1 (GlyT-1) Inhibitor,NCGC00263114-01,G8
SLC6A9,Glycine Transporter 1 (GlyT-1) Inhibitor,NCGC00263114-01,C5
AR,Androgen Receptor Antagonist,NCGC00263120-01,F2
AR,Androgen Receptor Antagonist,NCGC00263120-01,G8
AR,Androgen Receptor Antagonist,NCGC00263120-01,G9
AR,Androgen Receptor Antagonist,NCGC00263120-01,C5
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,G8
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,G9
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,C5
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,F2
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G8
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G9
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,C5
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G8
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G9
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,C5
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,F2
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G9
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C5
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,C8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,D10
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,F2
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263164-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
TUBB,Tubulin polymerization inhibitor,NCGC00263169-01,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,C5
AURKA,Aurora-A Inhibitor,NCGC00263178-01,F2
AURKA,Aurora-A Inhibitor,NCGC00263178-01,G8
AURKA,Aurora-A Inhibitor,NCGC00263178-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C5
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,F2
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,G8
WEE1,Wee1 Kinase Inhibitor,NCGC00263183-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263185-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263185-01,C5
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,F2
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G8
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G9
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,C8
MAP2K1,MEK inhibitor,NCGC00263187-01,D10
MAP2K1,MEK inhibitor,NCGC00263187-01,F2
MAP2K1,MEK inhibitor,NCGC00263187-01,G8
MAP2K1,MEK inhibitor,NCGC00263187-01,G9
NOTCH1,g-Secretase Inhibitor,NCGC00263188-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00263193-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263195-01,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00263198-01,C5
TEK,Tie-2 inhibitor,NCGC00263199-02,C8
TEK,Tie-2 inhibitor,NCGC00263199-02,G8
TEK,Tie-2 inhibitor,NCGC00263199-02,G9
TEK,Tie-2 inhibitor,NCGC00263199-02,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,D10
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,C5
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G9
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263214-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263214-01,C5
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,D10
MTOR,mTORC1 Inhibitor,NCGC00263216-02,F2
MTOR,mTORC1 Inhibitor,NCGC00263216-02,G8
MTOR,mTORC1 Inhibitor,NCGC00263216-02,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00263219-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C5
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,F2
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G9
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C5
FAS,Fatty acid synthase inhibitor,NCGC00263229-01,G8
FAS,Fatty acid synthase inhibitor,NCGC00263229-01,C5
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C5
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C5
PfATP6,artemesinin analogue,NCGC00263270-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,C5
FAS,FAS inhibitor,NCGC00263281-01,G8
FAS,FAS inhibitor,NCGC00263281-01,G9
FAS,FAS inhibitor,NCGC00263281-01,C5
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C5
NA,K(ATP) Channel Activators,NCGC00263564-02,F2
NA,K(ATP) Channel Activators,NCGC00263564-02,G8
NA,K(ATP) Channel Activators,NCGC00263564-02,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00263621-02,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C5
NA,Calcium Channel Blocker,NCGC00344506-01,G8
NA,Calcium Channel Blocker,NCGC00344506-01,C5
NA,Opioid receptor antagonist,NCGC00344511-02,F2
NA,Opioid receptor antagonist,NCGC00344511-02,G8
NA,Opioid receptor antagonist,NCGC00344511-02,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00344588-01,C5
NA,DOT1L Inhibitor,NCGC00344622-02,F2
NA,DOT1L Inhibitor,NCGC00344622-02,G8
NA,DOT1L Inhibitor,NCGC00344622-02,G9
NA,DOT1L Inhibitor,NCGC00344622-02,C5
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C5
ITK,ITK inhibitor,NCGC00344990-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,C5
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,G8
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,G9
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,D10
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345083-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345083-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345083-01,C5
JAK2,Jak2 inhibitor,NCGC00345461-02,F2
JAK2,Jak2 inhibitor,NCGC00345461-02,G8
JAK2,Jak2 inhibitor,NCGC00345461-02,G9
JAK2,Jak2 inhibitor,NCGC00345461-02,C5
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C5
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,C5
AKT1,PKB/Akt Inhibitor,NCGC00345795-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00345795-01,C5
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C5
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,F2
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C5
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C5
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C5
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345821-01,G8
AKT1,AKT1/2 Inhibitor,NCGC00345823-01,C5
LIMK1,LIMK Inhibitor,NCGC00345825-01,F2
LIMK1,LIMK Inhibitor,NCGC00345825-01,G8
LIMK1,LIMK Inhibitor,NCGC00345825-01,C5
MAPK8,JNK Inhibitor,NCGC00345826-01,F2
MAPK8,JNK Inhibitor,NCGC00345826-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00345832-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345837-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345837-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345837-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345838-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345838-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345838-01,F2
AKT1,AKT Inhibitor,NCGC00345840-01,G8
AKT1,AKT Inhibitor,NCGC00345840-01,G9
AKT1,AKT Inhibitor,NCGC00345840-01,C5
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C5
JAK2,Jak2 inhibitor,NCGC00345846-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345849-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345849-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345849-01,C5
MAPK8,JNK Inhibitor,NCGC00345850-01,C8
MAPK8,JNK Inhibitor,NCGC00345850-01,F2
MAPK8,JNK Inhibitor,NCGC00345850-01,G8
MAPK8,JNK Inhibitor,NCGC00345850-01,G9
MAPK8,JNK Inhibitor,NCGC00345850-01,C5
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,D10
PIK3CA,PI3K Inhibitor,NCGC00345851-01,G8
PIK3CA,PI3K Inhibitor,NCGC00345851-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C5
JAK2,Jak2 inhibitor,NCGC00345854-01,F2
JAK2,Jak2 inhibitor,NCGC00345854-01,G8
JAK2,Jak2 inhibitor,NCGC00345854-01,C5
BTK,BTK Inhibitor,NCGC00345857-01,F2
BTK,BTK Inhibitor,NCGC00345857-01,G8
BTK,BTK Inhibitor,NCGC00345857-01,C5
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G9
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C5
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346447-01,D10
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,F2
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G9
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,C5
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
MAP2K1,Mek Inhibitor,NCGC00346455-01,C5
FGFR,FGFR Inhibitor,NCGC00346459-01,C8
FGFR,FGFR Inhibitor,NCGC00346459-01,D10
FGFR,FGFR Inhibitor,NCGC00346459-01,G8
FGFR,FGFR Inhibitor,NCGC00346459-01,C5
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346484-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346484-01,C5
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,F2
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G8
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G9
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,C5
HDAC1,HDAC Inhibitor,NCGC00346486-01,D10
HDAC1,HDAC Inhibitor,NCGC00346486-01,F2
HDAC1,HDAC Inhibitor,NCGC00346486-01,G8
HDAC1,HDAC Inhibitor,NCGC00346486-01,G9
HDAC1,HDAC Inhibitor,NCGC00346486-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346508-01,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C5
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,F2
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G8
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G9
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,C5
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C5
NA,Polyether Antibiotic,NCGC00346524-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,C5
AURKA,Aurora A Inhibitor,NCGC00346525-01,F2
AURKA,Aurora A Inhibitor,NCGC00346525-01,G8
AURKA,Aurora A Inhibitor,NCGC00346525-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
NA,ATP synthase inhibitor,NCGC00346531-01,C5
NA,HCV NS5A Inhibitors,NCGC00346533-01,F2
NA,HCV NS5A Inhibitors,NCGC00346533-01,G8
NA,HCV NS5A Inhibitors,NCGC00346533-01,G9
PLK1,Polo-like Kinase-1 (Plk-1) Inhibitor,NCGC00346535-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346536-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346536-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346536-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,D10
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346539-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346541-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00346563-01,C8
MAP2K1,MEK inhibitor,NCGC00346567-01,D10
MAP2K1,MEK inhibitor,NCGC00346567-01,F2
MAP2K1,MEK inhibitor,NCGC00346567-01,G8
MAP2K1,MEK inhibitor,NCGC00346567-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346578-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C5
PfATP6,antimalarial agents,NCGC00346590-01,C8
PfATP6,antimalarial agents,NCGC00346590-01,G8
PfATP6,antimalarial agents,NCGC00346590-01,G9
PfATP6,antimalarial agents,NCGC00346590-01,C5
NA,5-HT Release Inhibitor,NCGC00346591-01,F2
NA,5-HT Release Inhibitor,NCGC00346591-01,G8
NA,5-HT Release Inhibitor,NCGC00346591-01,G9
NA,5-HT Release Inhibitor,NCGC00346591-01,C5
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G9
AKT1,PKB/Akt Inhibitor,NCGC00346621-01,C5
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
PIK3CG,PI3K gamma Inhibitor,NCGC00346625-01,C8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,D10
CHEK1,Chk1 Inhibitor,NCGC00346626-01,F2
CHEK1,Chk1 Inhibitor,NCGC00346626-01,G8
CHEK1,Chk1 Inhibitor,NCGC00346626-01,C5
GCK,Glucokinase activator,NCGC00346628-01,F2
GCK,Glucokinase activator,NCGC00346628-01,G8
GCK,Glucokinase activator,NCGC00346628-01,C5
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,C5
MTOR,mTOR inhibitor,NCGC00346634-01,C8
MTOR,mTOR inhibitor,NCGC00346634-01,D10
MTOR,mTOR inhibitor,NCGC00346634-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346635-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346640-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,C5
SRC,Src Kinase Inhibitors,NCGC00346644-01,F2
SRC,Src Kinase Inhibitors,NCGC00346644-01,G8
SRC,Src Kinase Inhibitors,NCGC00346644-01,G9
SRC,Src Kinase Inhibitors,NCGC00346644-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346649-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346649-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346649-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,D10
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346659-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346659-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C5
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G8
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G9
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C5
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,F2
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G8
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G9
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,C5
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,D10
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,F2
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,G8
PDPK1,Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors,NCGC00346687-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,C5
NA,photosensitizer,NCGC00346712-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,C5
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,F2
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G9
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,D10
PIK3CA,PI3K alpha Inhibitor,NCGC00346717-01,G8
PIK3CA,PI3K alpha Inhibitor,NCGC00346717-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C5
BACE1,beta-Secretase Inhibitor,NCGC00346719-01,G8
BACE1,beta-Secretase Inhibitor,NCGC00346719-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G9
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,C5
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,G8
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,G9
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,C5
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,F2
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,G8
TBXA2R,Prostanoid TP Agonist,NCGC00346741-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G9
LRRK2,Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors,NCGC00346807-01,C5
CDK1,CDK1/2/4/6,NCGC00346827-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
CDK1,CDK1/2/4/6,NCGC00346827-01,C5
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C5
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,F2
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G8
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G9
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,C5
PIM1,Pim 1/2/3 Kinase Inhibitor,NCGC00346935-01,G8
PIM1,Pim 1/2/3 Kinase Inhibitor,NCGC00346935-01,C5
NA,Thrombin Inhibitors,NCGC00346938-01,F2
NA,Thrombin Inhibitors,NCGC00346938-01,G8
NA,Thrombin Inhibitors,NCGC00346938-01,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346948-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,C5
LCK,Lck Kinase Inhibitors,NCGC00346955-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346955-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346955-01,C5
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,D10
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,F2
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,G8
ABL1,Bcr-Abl inhibitor,NCGC00346956-01,C5
LCK,Lck Kinase Inhibitors,NCGC00346959-01,F2
LCK,Lck Kinase Inhibitors,NCGC00346959-01,G8
LCK,Lck Kinase Inhibitors,NCGC00346959-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G9
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,C8
FLT3,FLT3,NCGC00346964-01,F2
FLT3,FLT3,NCGC00346964-01,G8
RIPK1,Receptor-interacting serine/threonine-protein kinase 1 (RIPK1),NCGC00346966-01,C5
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,F2
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G8
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G9
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,C5
NA,p97 ATPase Inhibitor,NCGC00347064-01,F2
NA,p97 ATPase Inhibitor,NCGC00347064-01,G8
NA,p97 ATPase Inhibitor,NCGC00347064-01,C5
NA,p97 ATPase Inhibitor,NCGC00347066-01,F2
NA,p97 ATPase Inhibitor,NCGC00347066-01,G8
NA,p97 ATPase Inhibitor,NCGC00347066-01,G9
NA,p97 ATPase Inhibitor,NCGC00347066-01,C5
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,C5
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C5
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,G8
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,G9
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347909-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347909-01,C5
NA,Mutant IDH1 Inhibitor,NCGC00347934-01,G8
TGBR1,TGF-b Inhibitor,NCGC00347947-01,C5
NA,Oct4 Activator,NCGC00347953-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,C5
SHH,Hedgehog agonist,NCGC00347954-01,F2
SHH,Hedgehog agonist,NCGC00347954-01,G8
SHH,Hedgehog agonist,NCGC00347954-01,G9
SHH,Hedgehog agonist,NCGC00347954-01,C5
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,F2
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G8
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G9
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,C5
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00348107-01,C5
HTR2A,5-HT2A Antagonists?,NCGC00013841-08,G9
HTR2A,5-HT2A Antagonists?,NCGC00013841-08,C5
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,F2
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G8
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,G9
SHH,Hedgehog pathway inhibitor,NCGC00014352-03,C5
NA,Calcium Channel Blocker,NCGC00014926-03,F2
NA,Calcium Channel Blocker,NCGC00014926-03,G8
NA,Calcium Channel Blocker,NCGC00014926-03,G9
NA,Calcium Channel Blocker,NCGC00014926-03,G8
CYP2C9,Cyp2C9 Inhibitor,NCGC00015049-18,G9
NA,immunosuppressant,NCGC00015060-19,C5
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,F2
NA,Muscarinic M3 Receptor Ligand,NCGC00015096-11,G9
GABRA1,GABA Modulators,NCGC00015191-06,C5
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,D10
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,F2
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,G9
BCL2L1,Bcl-xL inhibitor,NCGC00015225-03,C5
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G8
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00015264-08,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015300-05,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00015321-04,C5
NA,antimalarial agents,NCGC00015349-06,G8
NA,antimalarial agents,NCGC00015349-06,G9
NA,antimalarial agents,NCGC00015349-06,C5
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,G8
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,G9
PDE5A,Phosphodiesterase III/V (PDE5) inhibitor,NCGC00015385-12,F2
DRD2,Dopamine D2 Antagonist,NCGC00015436-09,G9
DRD2,Dopamine D2 Antagonist,NCGC00015436-09,C5
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,F2
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G8
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,G9
NA,Dopamine Reuptake Inhibitor,NCGC00015484-06,C5
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,F2
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G8
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,G9
OPRM1,mu-Opioid Antagonists,NCGC00015608-04,C5
NA,H+/K+-ATPase Inhibitor,NCGC00015615-14,G9
NA,H+/K+-ATPase Inhibitor,NCGC00015615-14,C5
HTR2A,5-HT2A Antagonists?,NCGC00015656-06,G9
HTR2A,5-HT2A Antagonists?,NCGC00015656-06,C5
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,F2
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G8
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,G9
PDE3A,Phosphodiesterase III (PDE3) Inhibitor,NCGC00015675-03,C5
GRM5,mgluR5 Antagonists,NCGC00015682-02,F2
GRM5,mgluR5 Antagonists,NCGC00015682-02,G8
GRM5,mgluR5 Antagonists,NCGC00015682-02,G9
GRM5,mgluR5 Antagonists,NCGC00015682-02,C5
NA,noradrenaline reuptake inhibitor,NCGC00015708-17,G9
NA,noradrenaline reuptake inhibitor,NCGC00015708-17,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00015718-06,C5
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,D10
STAT3,STAT-3 Inhibitor,NCGC00015735-12,F2
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G8
STAT3,STAT-3 Inhibitor,NCGC00015735-12,G9
STAT3,STAT-3 Inhibitor,NCGC00015735-12,C5
AR,Androgen Receptor Antagonist,NCGC00015754-15,G9
AR,Androgen Receptor Antagonist,NCGC00015754-15,C5
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,G8
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,G9
PDE10A,Phosphodiesterase X (PDE10) inhibitor,NCGC00015810-13,C5
NA,anti-arrythmia drug,NCGC00015819-11,F2
NA,anti-arrythmia drug,NCGC00015819-11,G8
NA,anti-arrythmia drug,NCGC00015819-11,G9
NA,anti-arrythmia drug,NCGC00015819-11,C5
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,D10
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,F2
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G8
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,G9
ICAM1,ICAM1 Expression Inhibitors,NCGC00015840-09,C5
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015856-08,C5
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,F2
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G8
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,G9
DRD2,Dopamine D2 Antagonist,NCGC00015883-08,C5
NA,Alkaloid anitpsychotic,NCGC00015888-04,F2
NA,Alkaloid anitpsychotic,NCGC00015888-04,G8
NA,Alkaloid anitpsychotic,NCGC00015888-04,G9
NA,Alkaloid anitpsychotic,NCGC00015888-04,C5
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,G8
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,G9
PDE4A,cAMP Phosphodiesterase Inhibitors,NCGC00016023-17,C5
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,F2
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,G9
ADRA2A,alpha2-Adrenoceptor Antagonists,NCGC00016035-12,C5
CNR1,Cannabinoid Receptor Agonist,NCGC00016210-06,G9
CNR1,Cannabinoid Receptor Agonist,NCGC00016210-06,C5
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,D10
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,F2
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G8
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,G9
PTP4A1,Protein Tyrosine Phosphatase (PTP) Inhibitors,NCGC00016526-11,C5
NA,antidiabetic drug,NCGC00016543-08,F2
NA,antidiabetic drug,NCGC00016543-08,G8
NA,antidiabetic drug,NCGC00016543-08,G9
NA,antidiabetic drug,NCGC00016543-08,C5
NA,vasodilator,NCGC00016831-04,G9
NA,vasodilator,NCGC00016831-04,C5
NA,Antifungal Agent,NCGC00017112-11,F2
NA,Antifungal Agent,NCGC00017112-11,G9
NA,Antifungal Agent,NCGC00017112-11,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00017324-08,C5
NA,Antifungal Agent,NCGC00017338-05,C8
NA,Antifungal Agent,NCGC00017338-05,D10
NA,Antifungal Agent,NCGC00017338-05,F2
NA,Antifungal Agent,NCGC00017338-05,G8
NA,Antifungal Agent,NCGC00017338-05,G9
NA,Antifungal Agent,NCGC00017338-05,C5
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,D10
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,F2
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G8
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,G9
NDUFAF1,NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor,NCGC00017358-14,C5
NA,Treatment of Osteoporosis,NCGC00018139-08,F2
NA,Treatment of Osteoporosis,NCGC00018139-08,G9
NA,Treatment of Osteoporosis,NCGC00018139-08,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G8
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00018158-08,C5
NA,Steroid hormone,NCGC00018176-04,G9
NA,Steroid hormone,NCGC00018176-04,C5
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,G8
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00018193-06,C5
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,F2
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G8
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,G9
NA,mitochondrial carnitine palmitoyltransferase-1 inhbitior,NCGC00018261-05,C5
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,F2
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G8
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,G9
CYP19A1,Aromatase Inhibitor,NCGC00018294-06,C5
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,F2
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G8
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,G9
NR1I3,Constitutive Androstane Receptor Agonist,NCGC00018296-08,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00023509-14,C5
NA,Antineoplastic Antibiotics,NCGC00024246-13,C8
NA,Antineoplastic Antibiotics,NCGC00024246-13,D10
NA,Antineoplastic Antibiotics,NCGC00024246-13,F2
NA,Antineoplastic Antibiotics,NCGC00024246-13,G8
NA,Antineoplastic Antibiotics,NCGC00024246-13,G9
NA,Antineoplastic Antibiotics,NCGC00024246-13,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00024415-39,C5
ESR1,Estrogen Receptor Antagonist,NCGC00024762-05,G9
ESR1,Estrogen Receptor Antagonist,NCGC00024762-05,C5
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,F2
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G8
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,G9
CYP19A1,Aromatase Inhibitor,NCGC00025000-08,C5
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,G8
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,G9
TACR2,Tachykinin NK2 Antagonist,NCGC00025092-02,C5
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,D10
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,G9
PGR,Progesterone Receptor Antagonist,NCGC00025179-13,C5
PAR1,PAR1 Antagonist,NCGC00025225-02,F2
PAR1,PAR1 Antagonist,NCGC00025225-02,G8
PAR1,PAR1 Antagonist,NCGC00025225-02,G9
PAR1,PAR1 Antagonist,NCGC00025225-02,C5
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,F2
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G8
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,G9
TBXA2R,Prostanoid TP Antagonist,NCGC00025325-03,C5
HTR1A,5-HT Reuptake Inhibitor,NCGC00025355-11,G9
HTR1A,5-HT Reuptake Inhibitor,NCGC00025355-11,C5
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,F2
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G8
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,G9
PRKDC,DNA-Directed RNA Polymerase Inhibitor,NCGC00090762-03,C5
NA,HIV Protease Inhibitors,NCGC00090782-07,G8
NA,HIV Protease Inhibitors,NCGC00090782-07,G9
NA,HIV Protease Inhibitors,NCGC00090782-07,C5
NA,Macrolide Antibiotic,NCGC00090808-03,G8
NA,Macrolide Antibiotic,NCGC00090808-03,G9
NA,Macrolide Antibiotic,NCGC00090808-03,C5
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,D10
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,F2
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,G9
CYP19A1,Aromatase Inhibitor,NCGC00091009-05,C5
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,D10
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,F2
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G8
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,G9
NA,TNFR1 (p55/CD120a) Modulator,NCGC00091112-08,C5
ESR1,Estrogen Receptor (ER) Agonist,NCGC00091544-08,G9
ESR1,Estrogen Receptor (ER) Agonist,NCGC00091544-08,G8
CDC25,Cell Division Cycle CDC25 Phosphatase Inhibitor,NCGC00092289-01,G9
CDC25,Cell Division Cycle CDC25 Phosphatase Inhibitor,NCGC00092289-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00092290-03,C5
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,D10
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,F2
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G8
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,G9
AKT1,PKB/Akt Inhibitor,NCGC00092314-04,C5
GRIN2A,NMDA Antagonist,NCGC00092329-01,G9
GRIN2A,NMDA Antagonist,NCGC00092329-01,C5
GRM1,mgluR1 Antagonists,NCGC00092375-02,F2
GRM1,mgluR1 Antagonists,NCGC00092375-02,G8
GRM1,mgluR1 Antagonists,NCGC00092375-02,G9
GRM1,mgluR1 Antagonists,NCGC00092375-02,C5
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,G8
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,G9
ADK,Adenosine Kinase Inhibitor,NCGC00092381-03,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00093976-06,C5
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,D10
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,F2
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G8
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,G9
AKR1C1,17-betahydroxysteroid dehydrogenase inhibitor,NCGC00094818-08,C5
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,D10
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,F2
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G8
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,G9
WNT1,Anticoccidial/Antibacterial,NCGC00095055-03,C5
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00095099-04,C5
HTR4,5-HT4 Partial Agonists,NCGC00095192-06,G9
NA,Antibacterial,NCGC00095264-05,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00159455-04,C5
NA,HIV Protease Inhibitors,NCGC00159461-03,G8
NA,HIV Protease Inhibitors,NCGC00159461-03,G9
NA,HIV Protease Inhibitors,NCGC00159461-03,C5
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,F2
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G8
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,G9
HTR2A,5-HT1A/2A Antagonists?,NCGC00159510-04,C5
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,D10
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,F2
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G8
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,G9
HMGCR,HMG-CoA Reductase Inhibitor,NCGC00160531-01,C5
PSMD1,Proteasome Inhibitor,NCGC00161679-01,C8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,D10
PSMD1,Proteasome Inhibitor,NCGC00161679-01,F2
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G8
PSMD1,Proteasome Inhibitor,NCGC00161679-01,G9
NA,Glucocorticoid steroid,NCGC00161834-01,C5
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,F2
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G8
AKT1,PKB/Akt Inhibitor,NCGC00162073-05,G9
NA,Vacuolar H+ ATPase (V-ATPase) Inhibitors,NCGC00162409-03,C5
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,D10
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,F2
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G8
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,G9
ADH1A,Alcohol Dehydrogenase Inhibitor,NCGC00162423-04,C5
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,D10
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,F2
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G8
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,G9
HDAC1,HDAC1 Inhibitor,NCGC00162453-10,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00163381-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00163424-03,C5
NA,Antineoplastic Antibiotics,NCGC00163548-02,C8
NA,Antineoplastic Antibiotics,NCGC00163548-02,D10
NA,Antineoplastic Antibiotics,NCGC00163548-02,F2
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,Antineoplastic Antibiotics,NCGC00163548-02,G9
NA,Antineoplastic Antibiotics,NCGC00163548-02,G8
NA,sesquiterpene natural product,NCGC00163620-02,G9
NA,sesquiterpene natural product,NCGC00163620-02,C5
PfATP6,antimalarial agents,NCGC00164600-03,C8
PfATP6,antimalarial agents,NCGC00164600-03,D10
PfATP6,antimalarial agents,NCGC00164600-03,F2
PfATP6,antimalarial agents,NCGC00164600-03,G8
PfATP6,antimalarial agents,NCGC00164600-03,G9
PfATP6,antimalarial agents,NCGC00164600-03,C5
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,D10
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,F2
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G8
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,G9
HMGCR,HMG-CoA Reductase Inhibitors,NCGC00164604-03,C5
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,F2
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G8
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,G9
FLT1,VEGFR-1/2/3 Inhibitor,NCGC00164631-03,C5
NA,K(ATP) Channel Blockers,NCGC00164637-04,G9
NA,K(ATP) Channel Blockers,NCGC00164637-04,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00165721-02,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,F2
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00165740-04,C5
PPARA,PPARalpha Antagonist,NCGC00165799-02,G8
PPARA,PPARalpha Antagonist,NCGC00165799-02,G9
PPARA,PPARalpha Antagonist,NCGC00165799-02,C5
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,D10
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,F2
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G8
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,G9
IKBKB,IKK-2 Inhibitor,NCGC00165811-03,C5
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,F2
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G8
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,G9
SIGMAR1,sigma1/2 Receptor Agonist,NCGC00165875-03,C5
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,D10
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G8
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,G9
ADORA3,Adenosine A3 Antagonists,NCGC00165880-04,C5
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,D10
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,F2
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G8
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,G9
TGBR1,TGF-bR1 (ALK4/5) Inhibitor,NCGC00165889-02,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00165902-02,C5
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,D10
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,F2
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G8
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,G9
RASAL1,Dual RASGAP/Erk inhibitor,NCGC00167403-03,C5
NA,Antifungal Agent,NCGC00167430-03,F2
NA,Antifungal Agent,NCGC00167430-03,G9
NA,Antifungal Agent,NCGC00167430-03,C5
NA,antimalarial agents,NCGC00167490-02,F2
NA,antimalarial agents,NCGC00167490-02,G8
NA,antimalarial agents,NCGC00167490-02,G9
NA,antimalarial agents,NCGC00167490-02,C5
NA,antimalarial agents,NCGC00167496-02,C8
NA,antimalarial agents,NCGC00167496-02,D10
NA,antimalarial agents,NCGC00167496-02,F2
NA,antimalarial agents,NCGC00167496-02,G8
NA,antimalarial agents,NCGC00167496-02,G9
NA,antimalarial agents,NCGC00167496-02,C5
NA,Macrolide Antibiotic,NCGC00167506-03,G8
NA,Macrolide Antibiotic,NCGC00167506-03,G9
NA,Macrolide Antibiotic,NCGC00167506-03,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00167507-03,C5
CASP3,Procaspase 3 Activator,NCGC00167785-02,D10
CASP3,Procaspase 3 Activator,NCGC00167785-02,F2
CASP3,Procaspase 3 Activator,NCGC00167785-02,G8
CASP3,Procaspase 3 Activator,NCGC00167785-02,G9
CASP3,Procaspase 3 Activator,NCGC00167785-02,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00167832-04,C5
NA,Ketolide antibiotic,NCGC00167967-01,F2
NA,Ketolide antibiotic,NCGC00167967-01,G8
NA,Ketolide antibiotic,NCGC00167967-01,G9
NA,Ketolide antibiotic,NCGC00167967-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00168459-04,C5
NA,HIV Protease Inhibitors,NCGC00168773-01,F2
NA,HIV Protease Inhibitors,NCGC00168773-01,G8
NA,HIV Protease Inhibitors,NCGC00168773-01,G9
NA,HIV Protease Inhibitors,NCGC00168773-01,C5
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,D10
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,F2
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G8
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,G9
NA,K+/ATP Signaling Inhibitor,NCGC00173359-06,C5
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G8
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,G9
ACE,Angiotensin-I Converting Enzyme Inhibitor,NCGC00178127-04,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00178913-04,C5
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,D10
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,F2
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,G9
NA,PRL Phosphatase Inhibitors,NCGC00179034-08,C5
NA,Polyether Antibiotic,NCGC00179454-04,C8
NA,Polyether Antibiotic,NCGC00179454-04,F2
NA,Polyether Antibiotic,NCGC00179454-04,G8
NA,Polyether Antibiotic,NCGC00179454-04,G9
NA,Polyether Antibiotic,NCGC00179454-04,C5
NA,Antifungal Agent,NCGC00179596-04,F2
NA,Antifungal Agent,NCGC00179596-04,G9
NA,Antifungal Agent,NCGC00179596-04,C5
NA,Antifungal Agent,NCGC00179642-04,F2
NA,Antifungal Agent,NCGC00179642-04,G8
NA,Antifungal Agent,NCGC00179642-04,G9
NA,Antifungal Agent,NCGC00179642-04,C5
NA,Glucocorticoid steroid,NCGC00179649-07,G9
NA,Iron Chelator,NCGC00181754-01,C5
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,F2
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,G9
CYSLTR1,Leukotriene CysLT1/2 (LTD4) Antagonist,NCGC00181765-01,G8
COMT,catechol-O-methyltransferase (COMT),NCGC00181767-01,G9
COMT,catechol-O-methyltransferase (COMT),NCGC00181767-01,C5
HTR1B,5-HT1B Agonist,NCGC00181786-03,C8
HTR1B,5-HT1B Agonist,NCGC00181786-03,D10
HTR1B,5-HT1B Agonist,NCGC00181786-03,G8
HTR1B,5-HT1B Agonist,NCGC00181786-03,G9
HTR1B,5-HT1B Agonist,NCGC00181786-03,C5
SYK,Syk Kinase inhibitor,NCGC00182051-02,F2
SYK,Syk Kinase inhibitor,NCGC00182051-02,G8
SYK,Syk Kinase inhibitor,NCGC00182051-02,G9
SYK,Syk Kinase inhibitor,NCGC00182051-02,C5
NA,HIV Protease Inhibitors,NCGC00182552-03,F2
NA,HIV Protease Inhibitors,NCGC00182552-03,G8
NA,HIV Protease Inhibitors,NCGC00182552-03,G9
NA,HIV Protease Inhibitors,NCGC00182552-03,C5
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,D10
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,F2
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G8
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,G9
NAMPT,NMPRTase Inhibitor,NCGC00182868-02,C5
NA,Tetracycline Antibiotic,NCGC00183044-01,G8
NA,Tetracycline Antibiotic,NCGC00183044-01,G9
NA,Tetracycline Antibiotic,NCGC00183044-01,C5
NA,HIV Protease Inhibitors,NCGC00183130-01,F2
NA,HIV Protease Inhibitors,NCGC00183130-01,G8
NA,HIV Protease Inhibitors,NCGC00183130-01,G9
NA,HIV Protease Inhibitors,NCGC00183130-01,C5
NA,Calcium Channel Blocker,NCGC00183837-01,C8
NA,Calcium Channel Blocker,NCGC00183837-01,D10
NA,Calcium Channel Blocker,NCGC00183837-01,F2
NA,Calcium Channel Blocker,NCGC00183837-01,G8
NA,Calcium Channel Blocker,NCGC00183837-01,G9
NA,Calcium Channel Blocker,NCGC00183837-01,C5
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,F2
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G8
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,G9
ADRB1,beta1-Adrenoceptor Antagonists,NCGC00183875-01,C5
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,F2
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,G9
NA,H+/K+-ATPase Inhibitor,NCGC00186013-01,C5
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,D10
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,F2
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G8
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,G9
TGBR1,TGF-bR1 (ALK5) inhibitor,NCGC00186024-02,C5
GR1A1,AMPA Antagonist,NCGC00186046-02,G8
GR1A1,AMPA Antagonist,NCGC00186046-02,G9
GR1A1,AMPA Antagonist,NCGC00186046-02,C5
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,D10
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,F2
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G8
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,G9
NFKB1,NF-kappaB signaling Inhibitor,NCGC00186460-01,C5
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,F2
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G8
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,G9
BTK,Btk/Lck/Lyn inhibitor,NCGC00187912-03,C5
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,F2
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G8
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,G9
BCL2L1,Bcl-xL inhibitor,NCGC00188344-05,C5
MTOR,mTOR Inhibitor,NCGC00188346-01,C8
MTOR,mTOR Inhibitor,NCGC00188346-01,D10
MTOR,mTOR Inhibitor,NCGC00188346-01,G8
MTOR,mTOR Inhibitor,NCGC00188346-01,G9
MTOR,mTOR Inhibitor,NCGC00188346-01,C5
ITK,ITK inhibitor,NCGC00188382-04,C8
ITK,ITK inhibitor,NCGC00188382-04,D10
ITK,ITK inhibitor,NCGC00188382-04,F2
ITK,ITK inhibitor,NCGC00188382-04,G8
ITK,ITK inhibitor,NCGC00188382-04,G9
ITK,ITK inhibitor,NCGC00188382-04,C5
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,F2
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G8
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,G9
ADRA1A,alpha_:_beta-Adrenoceptor Antagonists,NCGC00188863-01,C5
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,F2
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G8
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,G9
DRD2,Dopamine D2 Antagonist,NCGC00188864-01,C5
CERS1,multi-kinase,NCGC00188865-02,F2
CERS1,multi-kinase,NCGC00188865-02,G8
CERS1,multi-kinase,NCGC00188865-02,G9
CERS1,multi-kinase,NCGC00188865-02,C5
RAC1,Rac1 inhibitor,NCGC00188866-01,F2
RAC1,Rac1 inhibitor,NCGC00188866-01,G9
RAC1,Rac1 inhibitor,NCGC00188866-01,C5
MAP2K1,MEK inhibitor,NCGC00189075-01,C8
MAP2K1,MEK inhibitor,NCGC00189075-01,D10
MAP2K1,MEK inhibitor,NCGC00189075-01,F2
MAP2K1,MEK inhibitor,NCGC00189075-01,G8
MAP2K1,MEK inhibitor,NCGC00189075-01,G9
MAP2K1,MEK inhibitor,NCGC00189075-01,C5
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,F2
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,G9
EHMT2,Histone-lysine N-methyltransferase EHMT2 Inhibitor,NCGC00189220-05,C5
BLM,BLM inhibitor,NCGC00189393-03,F2
BLM,BLM inhibitor,NCGC00189393-03,G8
BLM,BLM inhibitor,NCGC00189393-03,G9
BLM,BLM inhibitor,NCGC00189393-03,C5
ITK,ITK inhibitor,NCGC00229512-04,D10
ITK,ITK inhibitor,NCGC00229512-04,F2
ITK,ITK inhibitor,NCGC00229512-04,G8
ITK,ITK inhibitor,NCGC00229512-04,G9
ITK,ITK inhibitor,NCGC00229512-04,C5
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,F2
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G8
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,G9
PRKCA,PKCa_:_ PKCb_:_ PKCg inhbitor,NCGC00238452-02,C5
JARID2,JMJ inhibitor,NCGC00241036-02,G8
JARID2,JMJ inhibitor,NCGC00241036-02,G9
JARID2,JMJ inhibitor,NCGC00241036-02,C5
SRC,cSRC inhibitor,NCGC00241099-01,G9
SRC,cSRC inhibitor,NCGC00241099-01,C5
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,D10
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,F2
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G8
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,G9
PRKCA,PKC/flt3 inhibitor,NCGC00241102-02,C5
IRAK1,IRAK Inhibitor,NCGC00241410-01,F2
IRAK1,IRAK Inhibitor,NCGC00241410-01,G8
IRAK1,IRAK Inhibitor,NCGC00241410-01,G9
IRAK1,IRAK Inhibitor,NCGC00241410-01,C5
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,D10
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,F2
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G8
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,G9
ROCK1,ROCK 1_:_ ROCK 2 Inhibitor,NCGC00241982-03,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00242478-02,C5
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,D10
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,F2
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G8
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,G9
CHEK1,Chk1/2 Inhibitor,NCGC00242481-02,C5
MAPK7,ERK inhibitor,NCGC00242487-01,F2
MAPK7,ERK inhibitor,NCGC00242487-01,G9
MAPK7,ERK inhibitor,NCGC00242487-01,C5
SRC,cSRC inhibitor,NCGC00242490-02,C8
SRC,cSRC inhibitor,NCGC00242490-02,D10
SRC,cSRC inhibitor,NCGC00242490-02,F2
SRC,cSRC inhibitor,NCGC00242490-02,G8
SRC,cSRC inhibitor,NCGC00242490-02,G9
SRC,cSRC inhibitor,NCGC00242490-02,C5
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,F2
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G8
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,G9
NRC31,Glucocorticoid Receptor (GR) Agonist,NCGC00242504-01,C5
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,D10
PSMD1,Proteasome Inhibitor,NCGC00242506-02,F2
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G8
PSMD1,Proteasome Inhibitor,NCGC00242506-02,G9
PSMD1,Proteasome Inhibitor,NCGC00242506-02,C5
BIRC5,Survivin inhibitor,NCGC00242514-01,C8
BIRC5,Survivin inhibitor,NCGC00242514-01,D10
BIRC5,Survivin inhibitor,NCGC00242514-01,F2
BIRC5,Survivin inhibitor,NCGC00242514-01,G8
BIRC5,Survivin inhibitor,NCGC00242514-01,G9
BIRC5,Survivin inhibitor,NCGC00242514-01,C5
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,D10
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,F2
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G8
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,G9
JAK1,Jak/Tyk/Flt inhibitor,NCGC00244256-02,C5
JAK1,Jak1/2 inhibitor,NCGC00244257-01,C8
JAK1,Jak1/2 inhibitor,NCGC00244257-01,G9
JAK1,Jak1/2 inhibitor,NCGC00244257-01,C5
NA,antiinfluenza drug,NCGC00246387-02,F2
NA,antiinfluenza drug,NCGC00246387-02,G8
NA,antiinfluenza drug,NCGC00246387-02,G9
NA,antiinfluenza drug,NCGC00246387-02,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00247879-01,C5
JAK2,Jak2 inhibitor,NCGC00249346-02,C8
JAK2,Jak2 inhibitor,NCGC00249346-02,D10
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
JAK2,Jak2 inhibitor,NCGC00249346-02,G8
JAK2,Jak2 inhibitor,NCGC00249346-02,G9
JAK2,Jak2 inhibitor,NCGC00249346-02,F2
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,G8
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,G9
FLT1,VEGFR-2 inhibitor,NCGC00249393-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249611-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249611-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249611-03,C5
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,D10
PSMD1,Proteasome Inhibitor,NCGC00249612-01,F2
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G8
PSMD1,Proteasome Inhibitor,NCGC00249612-01,G9
PSMD1,Proteasome Inhibitor,NCGC00249612-01,C5
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,D10
PSMD1,Proteasome Inhibitor,NCGC00249613-03,F2
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G8
PSMD1,Proteasome Inhibitor,NCGC00249613-03,G9
PSMD1,Proteasome Inhibitor,NCGC00249613-03,C5
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,D10
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,F2
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G8
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,G9
CAMKK2,Calmodulin-Dependent Protein Kinase II Inhibitors,NCGC00250376-01,C5
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,D10
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,F2
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G8
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,G9
BRAF,Raf kinase B/C Inhibitor,NCGC00250380-01,C5
SMO,Smo Receptor Antagonist,NCGC00250382-01,C8
SMO,Smo Receptor Antagonist,NCGC00250382-01,D10
SMO,Smo Receptor Antagonist,NCGC00250382-01,F2
SMO,Smo Receptor Antagonist,NCGC00250382-01,G8
SMO,Smo Receptor Antagonist,NCGC00250382-01,G9
SMO,Smo Receptor Antagonist,NCGC00250382-01,C5
IKBKB,IKK-beta Inhibitor,NCGC00250384-01,G9
IKBKB,IKK-beta Inhibitor,NCGC00250384-01,C5
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,D10
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,F2
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G8
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,G9
IKBKE,IKK-epsilon Inhibitor,NCGC00250386-02,C5
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,D10
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G8
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,G9
PRKDC,DNA-Dependent Protein Kinase (DNA-PK) Inhibitor,NCGC00250387-02,C5
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,F2
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G8
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,G9
PDK2,Pyruvate Dehydrogenase Kinase 2 Inhibitor,NCGC00250391-01,D10
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,G8
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,G9
MTOR,mTORC1/2 Inhibitor,NCGC00250396-01,C5
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,C8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,D10
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,F2
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G9
CDK1,CDK1/2/4/6/7/9 Inhibitor,NCGC00250401-01,G8
MTOR,mTORC1/2 Inhibitor,NCGC00250405-01,G9
MTOR,mTORC1/2 Inhibitor,NCGC00250405-01,C5
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,F2
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G8
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,G9
BRD4,Bromodomain-Containing Protein 4 (Brd4_:_ HUNK1) Inhibitor,NCGC00250412-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,D10
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,F2
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G8
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,G9
BCL2L1,Bcl-xL inhibitor,NCGC00253562-02,C5
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,F2
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,G9
SLC6A4,Serotonin Transporter (SERT) Inhibitor,NCGC00253658-02,C5
NA,Antifungal Agent,NCGC00253713-02,F2
NA,Antifungal Agent,NCGC00253713-02,G8
NA,Antifungal Agent,NCGC00253713-02,G9
NA,Antifungal Agent,NCGC00253713-02,C5
SYK,Syk Kinase inhibitor,NCGC00253909-01,G8
SYK,Syk Kinase inhibitor,NCGC00253909-01,G9
SYK,Syk Kinase inhibitor,NCGC00253909-01,C5
JAK2,Jak2 inhibitor,NCGC00262608-02,C8
JAK2,Jak2 inhibitor,NCGC00262608-02,D10
JAK2,Jak2 inhibitor,NCGC00262608-02,F2
JAK2,Jak2 inhibitor,NCGC00262608-02,G8
JAK2,Jak2 inhibitor,NCGC00262608-02,G9
JAK2,Jak2 inhibitor,NCGC00262608-02,C5
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,F2
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G8
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,G9
TLR4,TLR4 (LPS) inhibitor,NCGC00263015-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263016-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263016-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263016-01,C5
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,F2
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G8
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,G9
SMO,Smoothened (Smo) receptor agonist,NCGC00263084-02,C5
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,D10
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,F2
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G8
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,G9
RPS6KA1,MAPKAP-K1 (RSK; p90Rsk) Inhibitor,NCGC00263086-01,C5
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,D10
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,F2
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G8
PIK3CA,PI3K/PDK1 Inhibitor,NCGC00263088-01,G9
CDK1,CDK 1 & 2 inhibitor,NCGC00263091-01,C5
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,F2
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G8
IL2,IL-12 Production Inhibitor,NCGC00263093-01,G9
IL2,IL-12 Production Inhibitor,NCGC00263093-01,C5
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,D10
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,G9
FLT1,VEGFR-1/2/3 inhibitor,NCGC00263097-01,C5
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,F2
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G8
ATM,ATM Kinase Inhibitor,NCGC00263099-01,G9
ATM,ATM Kinase Inhibitor,NCGC00263099-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00263101-01,C5
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,D10
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,F2
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G8
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,G9
KDR,VEGFR-2 Inhibitor,NCGC00263104-01,C5
PAR2,PAR2 Antagonist,NCGC00263107-01,G8
PAR2,PAR2 Antagonist,NCGC00263107-01,G9
PAR2,PAR2 Antagonist,NCGC00263107-01,C5
PAR1,PAR1 Antagonist,NCGC00263108-01,G8
PAR1,PAR1 Antagonist,NCGC00263108-01,G9
PAR1,PAR1 Antagonist,NCGC00263108-01,C5
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,G8
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,G9
TACR3,Tachykinin NK3 Antagonist,NCGC00263110-01,C5
AR,Androgen Receptor Antagonist,NCGC00263120-01,F2
AR,Androgen Receptor Antagonist,NCGC00263120-01,G8
AR,Androgen Receptor Antagonist,NCGC00263120-01,G9
AR,Androgen Receptor Antagonist,NCGC00263120-01,C5
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,G8
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,G9
SIGMAR1,sigma1 Receptor Agonist,NCGC00263126-01,C5
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,F2
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,G9
FAAH,Fatty Acid Amide Hydrolase (FAAH) Inhibitor,NCGC00263131-01,C5
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,F2
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G8
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,G9
RPS6KB1,p70 ribosomal S6 kinase (S6K1) inhibitor,NCGC00263134-01,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263136-03,C5
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G8
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,G9
ADORA1,Adenosine A1 Antagonist,NCGC00263139-01,C5
HSPA2,Heat Shock Protein 70 (hsp70) Inhibitor,NCGC00263143-01,G9
HSPA2,Heat Shock Protein 70 (hsp70) Inhibitor,NCGC00263143-01,C5
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,F2
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G8
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,G9
AKT1,Akt1/PKA Inhibitor,NCGC00263147-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00263149-01,C5
FGFR,FGFR Inhibitor,NCGC00263152-02,C8
FGFR,FGFR Inhibitor,NCGC00263152-02,D10
FGFR,FGFR Inhibitor,NCGC00263152-02,F2
FGFR,FGFR Inhibitor,NCGC00263152-02,G8
FGFR,FGFR Inhibitor,NCGC00263152-02,G9
FGFR,FGFR Inhibitor,NCGC00263152-02,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263153-05,C5
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,D10
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,F2
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G8
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,G9
HDAC1,Histone Deacetylase (HDAC) 1/2 Inhibitor,NCGC00263155-01,C8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,D10
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,F2
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G8
PDGFRA,PDGFR alpha Inhibitor,NCGC00263158-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00263159-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00263165-01,C5
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,D10
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,F2
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G8
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,G9
BCL2L1,Bcl-xL inhibitor,NCGC00263166-01,C5
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,D10
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,G9
CDK2,CDK2_:_7_:_9 Inhibitor,NCGC00263167-02,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263170-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00263180-01,C5
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,F2
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G8
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,G9
PIM1,Pim-1/Flt3 Inhibitor,NCGC00263186-02,C8
MAP2K1,MEK inhibitor,NCGC00263187-01,D10
MAP2K1,MEK inhibitor,NCGC00263187-01,F2
MAP2K1,MEK inhibitor,NCGC00263187-01,G8
MAP2K1,MEK inhibitor,NCGC00263187-01,G9
CDK2,CDK2/Cyclin A Inhibitor,NCGC00263191-01,C5
TEK,Tie-2 inhibitor,NCGC00263199-02,C8
TEK,Tie-2 inhibitor,NCGC00263199-02,G8
TEK,Tie-2 inhibitor,NCGC00263199-02,G9
TEK,Tie-2 inhibitor,NCGC00263199-02,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,D10
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,F2
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00263201-01,C5
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,F2
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G8
LCK,Lck Kinase Inhibitors,NCGC00263206-02,G9
LCK,Lck Kinase Inhibitors,NCGC00263206-02,C5
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,F2
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G8
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,G9
SMO,Smoothened (Smo) Receptor Antagonist,NCGC00263210-01,C5
TRPV4,TRPV4 Antagonist,NCGC00263214-01,F2
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G8
TRPV4,TRPV4 Antagonist,NCGC00263214-01,G9
TRPV4,TRPV4 Antagonist,NCGC00263214-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263220-02,C5
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,F2
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G8
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,G9
IDO1,Indoleamine 2_:_3-dioxygenase (IDO) inhibitor,NCGC00263222-01,C5
PfATP6,artemesinin analogue,NCGC00263265-01,C8
PfATP6,artemesinin analogue,NCGC00263265-01,D10
PfATP6,artemesinin analogue,NCGC00263265-01,F2
PfATP6,artemesinin analogue,NCGC00263265-01,G8
PfATP6,artemesinin analogue,NCGC00263265-01,G9
PfATP6,artemesinin analogue,NCGC00263265-01,C5
PfATP6,artemesinin analogue,NCGC00263268-01,C8
PfATP6,artemesinin analogue,NCGC00263268-01,D10
PfATP6,artemesinin analogue,NCGC00263268-01,F2
PfATP6,artemesinin analogue,NCGC00263268-01,G8
PfATP6,artemesinin analogue,NCGC00263268-01,G9
PfATP6,artemesinin analogue,NCGC00263268-01,C5
PfATP6,artemesinin analogue,NCGC00263270-01,C8
PfATP6,artemesinin analogue,NCGC00263270-01,D10
PfATP6,artemesinin analogue,NCGC00263270-01,F2
PfATP6,artemesinin analogue,NCGC00263270-01,G8
PfATP6,artemesinin analogue,NCGC00263270-01,G9
PfATP6,artemesinin analogue,NCGC00263270-01,C5
FAS,FAS inhibitor,NCGC00263281-01,G8
FAS,FAS inhibitor,NCGC00263281-01,G9
FAS,FAS inhibitor,NCGC00263281-01,C5
NA,50S Ribosomal Protein Inhibitors,NCGC00263531-03,G9
NA,50S Ribosomal Protein Inhibitors,NCGC00263531-03,C5
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,F2
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,G9
HTR2A,5-HT2A Antagonists?,NCGC00263539-03,C5
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,D10
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,F2
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G8
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,G9
USP10,Ubiquitin Specific Peptidase (USP10/13) Inhibitors,NCGC00263555-02,C5
NA,K(ATP) Channel Activators,NCGC00263564-02,F2
NA,K(ATP) Channel Activators,NCGC00263564-02,G8
NA,K(ATP) Channel Activators,NCGC00263564-02,G9
NA,K(ATP) Channel Activators,NCGC00263564-02,C8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00263617-05,C5
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,D10
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,F2
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G8
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,G9
TOP2A,DNA Topoisomerase II Inhibitors,NCGC00263918-04,C5
MPL,Thrombopoietin Receptor (TpoR) Agonists,NCGC00274067-01,G9
MPL,Thrombopoietin Receptor (TpoR) Agonists,NCGC00274067-01,C5
NA,cytochrome inhibitor,NCGC00274068-02,G9
NA,cytochrome inhibitor,NCGC00274068-02,C5
NA,lineage-specific differentiation enhancer,NCGC00344053-01,G9
NA,lineage-specific differentiation enhancer,NCGC00344053-01,F2
NA,Renal cell growth inhibition,NCGC00344081-02,G9
NA,Renal cell growth inhibition,NCGC00344081-02,C5
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344509-01,G9
CASR,Calcium-Sensing Receptor (CaSR) Agonists,NCGC00344509-01,C5
NA,Opioid receptor antagonist,NCGC00344511-02,F2
NA,Opioid receptor antagonist,NCGC00344511-02,G8
NA,Opioid receptor antagonist,NCGC00344511-02,G9
NA,Opioid receptor antagonist,NCGC00344511-02,C5
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,F2
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,G9
OPRL1,ORL1 (OP4_:_ NOP) Antagonists,NCGC00344513-01,C5
NA,DOT1L Inhibitor,NCGC00344622-02,F2
NA,DOT1L Inhibitor,NCGC00344622-02,G8
NA,DOT1L Inhibitor,NCGC00344622-02,G9
NA,DOT1L Inhibitor,NCGC00344622-02,C5
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,D10
PSMD1,Proteasome Inhibitor,NCGC00344630-01,F2
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G8
PSMD1,Proteasome Inhibitor,NCGC00344630-01,G9
PSMD1,Proteasome Inhibitor,NCGC00344630-01,C5
ITK,ITK inhibitor,NCGC00344990-01,C8
ITK,ITK inhibitor,NCGC00344990-01,D10
ITK,ITK inhibitor,NCGC00344990-01,F2
ITK,ITK inhibitor,NCGC00344990-01,G8
ITK,ITK inhibitor,NCGC00344990-01,G9
ITK,ITK inhibitor,NCGC00344990-01,C5
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,G8
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,G9
PDE4A,Phosphodiesterase IIII D (PDE4D) inhibitor,NCGC00345018-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,D10
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345082-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345082-01,C5
NA,lineage-specific differentiation enhancer,NCGC00345083-01,G8
NA,lineage-specific differentiation enhancer,NCGC00345083-01,G9
NA,lineage-specific differentiation enhancer,NCGC00345083-01,C5
SHH,Hedgehog antagonist,NCGC00345084-01,F2
SHH,Hedgehog antagonist,NCGC00345084-01,G9
SHH,Hedgehog antagonist,NCGC00345084-01,C5
JAK2,Jak2 inhibitor,NCGC00345461-02,F2
JAK2,Jak2 inhibitor,NCGC00345461-02,G8
JAK2,Jak2 inhibitor,NCGC00345461-02,G9
JAK2,Jak2 inhibitor,NCGC00345461-02,C5
HDAC1,HDAC Inhibitor,NCGC00345539-02,C8
HDAC1,HDAC Inhibitor,NCGC00345539-02,D10
HDAC1,HDAC Inhibitor,NCGC00345539-02,F2
HDAC1,HDAC Inhibitor,NCGC00345539-02,G8
HDAC1,HDAC Inhibitor,NCGC00345539-02,G9
HDAC1,HDAC Inhibitor,NCGC00345539-02,C5
IKBKB,IKK Inhibitor,NCGC00345782-01,C8
IKBKB,IKK Inhibitor,NCGC00345782-01,D10
IKBKB,IKK Inhibitor,NCGC00345782-01,F2
IKBKB,IKK Inhibitor,NCGC00345782-01,G8
IKBKB,IKK Inhibitor,NCGC00345782-01,G9
IKBKB,IKK Inhibitor,NCGC00345782-01,C5
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C8
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,F2
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,G9
PAK4,p21-Activated Kinase 4 (PAK4) Inhibitors,NCGC00345784-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00345792-01,C5
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,G8
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,G9
MET,HGFR (MET; c-Met) Inhibitor,NCGC00345793-01,C5
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,D10
PSMD1,Proteasome Inhibitor,NCGC00345799-01,F2
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G8
PSMD1,Proteasome Inhibitor,NCGC00345799-01,G9
PSMD1,Proteasome Inhibitor,NCGC00345799-01,C5
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,F2
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G8
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,G9
IMPDH1,Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors,NCGC00345803-01,C5
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,D10
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,F2
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G8
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,G9
CDK1,CDK1/2/3/7/9 inhibitor,NCGC00345809-01,C5
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,D10
STAT3,STAT-3 Inhibitor,NCGC00345811-01,F2
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G8
STAT3,STAT-3 Inhibitor,NCGC00345811-01,G9
STAT3,STAT-3 Inhibitor,NCGC00345811-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00345834-01,F2
AKT1,AKT Inhibitor,NCGC00345840-01,G8
AKT1,AKT Inhibitor,NCGC00345840-01,G9
AKT1,AKT Inhibitor,NCGC00345840-01,C5
JAK2,Jak2 inhibitor,NCGC00345845-01,C8
JAK2,Jak2 inhibitor,NCGC00345845-01,D10
JAK2,Jak2 inhibitor,NCGC00345845-01,F2
JAK2,Jak2 inhibitor,NCGC00345845-01,G8
JAK2,Jak2 inhibitor,NCGC00345845-01,G9
JAK2,Jak2 inhibitor,NCGC00345845-01,C5
JAK2,Jak2 inhibitor,NCGC00345846-01,C8
JAK2,Jak2 inhibitor,NCGC00345846-01,D10
JAK2,Jak2 inhibitor,NCGC00345846-01,F2
JAK2,Jak2 inhibitor,NCGC00345846-01,G8
JAK2,Jak2 inhibitor,NCGC00345846-01,G9
JAK2,Jak2 inhibitor,NCGC00345846-01,C5
MAPK8,JNK Inhibitor,NCGC00345850-01,C8
MAPK8,JNK Inhibitor,NCGC00345850-01,F2
MAPK8,JNK Inhibitor,NCGC00345850-01,G8
MAPK8,JNK Inhibitor,NCGC00345850-01,G9
MAPK8,JNK Inhibitor,NCGC00345850-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00345852-01,C5
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,F2
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G8
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,G9
FLT1,VEGFR-2 (FLK-1/KDR) Inhibitors,NCGC00345858-01,C5
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,F2
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,G9
AVPR1A,Vasopressin (AVP) V1a/V2 Antagonists,NCGC00345881-02,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346438-01,C5
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,F2
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,G9
SLC6A3,Dopamine Transporter (DAT) Inhibitor,NCGC00346439-01,C5
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,C8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,F2
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G8
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,G9
SPHK2,Sphingosine Kinase 2 (SphK2) Inhibitors,NCGC00346441-01,D10
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,F2
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G8
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,G9
AKT1,PKB/Akt Inhibitor,NCGC00346450-01,C5
MAP2K1,Mek Inhibitor,NCGC00346455-01,C8
MAP2K1,Mek Inhibitor,NCGC00346455-01,D10
MAP2K1,Mek Inhibitor,NCGC00346455-01,F2
MAP2K1,Mek Inhibitor,NCGC00346455-01,G8
MAP2K1,Mek Inhibitor,NCGC00346455-01,G9
MAP2K1,Mek Inhibitor,NCGC00346455-01,C5
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,D10
PSMD1,Proteasome Inhibitor,NCGC00346469-01,F2
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G8
PSMD1,Proteasome Inhibitor,NCGC00346469-01,G9
PSMD1,Proteasome Inhibitor,NCGC00346469-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346484-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346484-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346484-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346484-01,C5
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,F2
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G8
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,G9
IGFR1,IGF-1R Inhibitor,NCGC00346485-01,C5
HDAC1,HDAC Inhibitor,NCGC00346486-01,D10
HDAC1,HDAC Inhibitor,NCGC00346486-01,F2
HDAC1,HDAC Inhibitor,NCGC00346486-01,G8
HDAC1,HDAC Inhibitor,NCGC00346486-01,G9
HDAC1,HDAC Inhibitor,NCGC00346486-01,C5
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,D10
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,F2
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G8
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,G9
HDAC1,HDAC1 Inhibitor,NCGC00346487-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346500-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346500-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346500-01,C5
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,F2
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,G9
NOTCH1,g-Secretase Inhibitor,NCGC00346504-01,C5
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,D10
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,F2
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G8
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,G9
PIK3CA,PI3Kalpha inhibitor,NCGC00346509-01,C5
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,F2
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G8
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,G9
ABL1_:_ LYN,Bcr-Abl Kinase Inhibitor,NCGC00346514-01,C5
NA,Macrolide Antibiotic,NCGC00346523-01,C8
NA,Macrolide Antibiotic,NCGC00346523-01,D10
NA,Macrolide Antibiotic,NCGC00346523-01,F2
NA,Macrolide Antibiotic,NCGC00346523-01,G8
NA,Macrolide Antibiotic,NCGC00346523-01,G9
NA,Macrolide Antibiotic,NCGC00346523-01,C5
NA,Polyether Antibiotic,NCGC00346524-01,C8
NA,Polyether Antibiotic,NCGC00346524-01,D10
NA,Polyether Antibiotic,NCGC00346524-01,F2
NA,Polyether Antibiotic,NCGC00346524-01,G8
NA,Polyether Antibiotic,NCGC00346524-01,G9
NA,Polyether Antibiotic,NCGC00346524-01,C5
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346530-01,C5
NA,HCV NS5A Inhibitors,NCGC00346533-01,F2
NA,HCV NS5A Inhibitors,NCGC00346533-01,G8
NA,HCV NS5A Inhibitors,NCGC00346533-01,G9
NA,HCV NS5A Inhibitors,NCGC00346533-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346536-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346536-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346536-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346536-01,C5
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,D10
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,F2
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G8
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,G9
MAPK14,p38 MAPK Inhibitor,NCGC00346537-01,C5
NA,Antifungal Agent,NCGC00346538-01,C8
NA,Antifungal Agent,NCGC00346538-01,F2
NA,Antifungal Agent,NCGC00346538-01,G9
NA,Antifungal Agent,NCGC00346538-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346542-01,G9
NA,Calcitonin Gene-Related Peptides (CGRP) Antagonists,NCGC00346546-01,C8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,D10
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,F2
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G8
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,G9
MAP2K1,Mek 1/2 inhibitor,NCGC00346552-01,C5
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,F2
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,G9
TEK,Tie-2 kinase inhibitor,NCGC00346554-01,C5
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,F2
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,G9
ADRA1A,alpha1-Adrenoceptor Antagonists,NCGC00346558-01,C8
MAP2K1,MEK inhibitor,NCGC00346567-01,D10
MAP2K1,MEK inhibitor,NCGC00346567-01,F2
MAP2K1,MEK inhibitor,NCGC00346567-01,G8
MAP2K1,MEK inhibitor,NCGC00346567-01,G9
MAP2K1,MEK inhibitor,NCGC00346567-01,C5
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,F2
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,G9
GPR119,Glucose-Dependent Insulinotropic Receptor (GDIR_:_ GPR119) Agonists,NCGC00346568-01,C5
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,D10
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,F2
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G8
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,G9
ERBB2,HER2 (erbB2) Inhibitor,NCGC00346582-01,C5
PfATP6,antimalarial agents,NCGC00346590-01,C8
PfATP6,antimalarial agents,NCGC00346590-01,G8
PfATP6,antimalarial agents,NCGC00346590-01,G9
PfATP6,antimalarial agents,NCGC00346590-01,C5
NA,5-HT Release Inhibitor,NCGC00346591-01,F2
NA,5-HT Release Inhibitor,NCGC00346591-01,G8
NA,5-HT Release Inhibitor,NCGC00346591-01,G9
NA,5-HT Release Inhibitor,NCGC00346591-01,C5
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G8
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,G9
PDE5A,Phosphodiesterase V (PDE5) inhibitor,NCGC00346592-01,C5
GRM2,mgluR2/3 Agonists,NCGC00346612-01,G9
GRM2,mgluR2/3 Agonists,NCGC00346612-01,C5
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,F2
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G8
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,G9
PDE4A,Phosphodiesterase IIII (PDE4) inhibitor,NCGC00346620-01,C5
SYK,Syk Kinase inhibitor,NCGC00346622-01,C8
SYK,Syk Kinase inhibitor,NCGC00346622-01,D10
SYK,Syk Kinase inhibitor,NCGC00346622-01,F2
SYK,Syk Kinase inhibitor,NCGC00346622-01,G8
SYK,Syk Kinase inhibitor,NCGC00346622-01,G9
SYK,Syk Kinase inhibitor,NCGC00346622-01,C5
NA,HIV Integrase Inhibitors,NCGC00346629-01,F2
NA,HIV Integrase Inhibitors,NCGC00346629-01,G9
NA,HIV Integrase Inhibitors,NCGC00346629-01,C5
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,C8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,D10
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,F2
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G8
PDE10A,Phosphodiesterase PDE10A Inhibitors,NCGC00346630-01,G9
CDK1,CDK1/2/4 Inhibitor,NCGC00346632-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346633-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346643-01,C5
SRC,Src Kinase Inhibitors,NCGC00346644-01,F2
SRC,Src Kinase Inhibitors,NCGC00346644-01,G8
SRC,Src Kinase Inhibitors,NCGC00346644-01,G9
SRC,Src Kinase Inhibitors,NCGC00346644-01,C5
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,D10
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,F2
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G8
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,G9
AURKA,Aurora Kinase Inhibitor,NCGC00346652-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,D10
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,F2
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346654-01,C5
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,D10
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,F2
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G8
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,G9
CDK1,CDK1/2/5/9 inhibitor,NCGC00346656-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346658-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346674-01,C5
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,F2
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G8
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,G9
AURKA,Aurora-A/B/C Kinase Inhibitor,NCGC00346676-01,C8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,D10
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G8
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346678-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346681-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346681-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346681-01,C5
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,F2
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G8
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,G9
PIKFYVE,PIKfyve Inhibitor,NCGC00346683-01,C5
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,F2
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,G9
HSP90AB1,Heat Shock Protein 90 (hsp90) Inhibitor,NCGC00346685-01,C5
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,D10
PIK3CA,PI3K Inhibitor,NCGC00346692-01,F2
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G8
PIK3CA,PI3K Inhibitor,NCGC00346692-01,G9
PIK3CA,PI3K Inhibitor,NCGC00346692-01,C5
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,G8
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,G9
MTOR,mTORC1/2 inhibitor,NCGC00346698-01,C5
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,F2
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,G9
COX10,Farnesyltransferase Inhibitor,NCGC00346707-01,C5
NA,photosensitizer,NCGC00346712-01,C8
NA,photosensitizer,NCGC00346712-01,D10
NA,photosensitizer,NCGC00346712-01,F2
NA,photosensitizer,NCGC00346712-01,G8
NA,photosensitizer,NCGC00346712-01,G9
NA,photosensitizer,NCGC00346712-01,C5
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,F2
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G8
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,G9
BRAF,Raf kinase B Inhibitor,NCGC00346716-01,C5
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,D10
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,F2
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G8
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,G9
PDGFRB,PDGFR beta inhibitor,NCGC00346718-01,C5
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,D10
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,F2
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G8
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,G9
EGFR,EGFR (HER1; erbB1) inhibitor,NCGC00346724-01,C5
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,F2
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G8
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,G9
ABCBA,P-Glycoprotein (MDR-1) Inhibitor,NCGC00346735-01,C5
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,G8
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,G9
KCNQ1,Voltage-Gated K(V) 7 (KCNQ) Channel Activator,NCGC00346739-01,C5
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,D10
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,F2
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G8
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,G9
HDAC1,Histone Deacetylase (HDAC) Inhibitor,NCGC00346743-01,C5
CDK1,CDK1/2/4/6,NCGC00346827-01,C8
CDK1,CDK1/2/4/6,NCGC00346827-01,D10
CDK1,CDK1/2/4/6,NCGC00346827-01,F2
CDK1,CDK1/2/4/6,NCGC00346827-01,G8
CDK1,CDK1/2/4/6,NCGC00346827-01,G9
CDK1,CDK1/2/4/6,NCGC00346827-01,C5
MGLL,Monoacylglycerol lipase (MAGL) inhibitor,NCGC00346837-01,G9
MGLL,Monoacylglycerol lipase (MAGL) inhibitor,NCGC00346837-01,C5
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,D10
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,F2
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G8
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,G9
PTK2,Focal Adhesion Kinase (FAK) Inhibitor,NCGC00346931-01,C5
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,F2
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G8
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,G9
LCK,Lyn Kinase Inhibitor,NCGC00346933-01,C5
NA,Thrombin Inhibitors,NCGC00346938-01,F2
NA,Thrombin Inhibitors,NCGC00346938-01,G8
NA,Thrombin Inhibitors,NCGC00346938-01,G9
NA,Thrombin Inhibitors,NCGC00346938-01,C5
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C8
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,D10
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,G9
CDK1,CDK1/2 Inhibitor,NCGC00346940-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,D10
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346951-01,C5
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,F2
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G8
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,G9
CDK4,CDK4/6 Inhibitor,NCGC00346952-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00346961-01,C5
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,F2
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G8
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,G9
CSF1R,CSF1R (c-FMS) Inhibitor,NCGC00346963-01,C5
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,F2
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G8
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,G9
SPHK1,Sphingosine Kinase 1 (SphK1) Inhibitors,NCGC00346972-01,C5
NA,p97 ATPase Inhibitor,NCGC00347066-01,F2
NA,p97 ATPase Inhibitor,NCGC00347066-01,G8
NA,p97 ATPase Inhibitor,NCGC00347066-01,G9
NA,p97 ATPase Inhibitor,NCGC00347066-01,C5
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,F2
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G8
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,G9
DDR1,discoidin domain receptor tyrosine kinase (DDR1),NCGC00347217-01,C5
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,D10
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,F2
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G8
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,G9
AKT1,PKB alpha/Akt1 Inhibitors,NCGC00347278-01,C5
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,C8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,D10
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G8
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,G9
NA,mucosa associated lymphoid tissue lymphoma translocation 1 (MALT1) Inhibitor,NCGC00347285-01,F2
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,G8
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,G9
P2RX3,P2X3/P2X2 Receptor Antagonist,NCGC00347903-01,C5
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,D10
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,F2
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G8
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,G9
P2RX7,P2X7 Receptor Antagonist,NCGC00347904-01,C5
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,F2
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,G9
SIRT2,Histone Deacetylase SIRT2 Inhibitors,NCGC00347936-01,C5
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,D10
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347948-01,C5
WNT5A,Wnt Signaling Inhibitor,NCGC00347949-01,G9
WNT5A,Wnt Signaling Inhibitor,NCGC00347949-01,C5
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,F2
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,G9
NA,Porcupine (Wnt) Inhibitor,NCGC00347950-01,C5
NA,Oct4 Activator,NCGC00347953-01,C8
NA,Oct4 Activator,NCGC00347953-01,D10
NA,Oct4 Activator,NCGC00347953-01,F2
NA,Oct4 Activator,NCGC00347953-01,G8
NA,Oct4 Activator,NCGC00347953-01,G9
NA,Oct4 Activator,NCGC00347953-01,C5
SHH,Hedgehog agonist,NCGC00347954-01,F2
SHH,Hedgehog agonist,NCGC00347954-01,G8
SHH,Hedgehog agonist,NCGC00347954-01,G9
SHH,Hedgehog agonist,NCGC00347954-01,C5
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,F2
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G8
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,G9
NR1D1,Rev-erb alpha agonist,NCGC00347956-01,C5
NA,beta Cell Proliferation Inducer,NCGC00347958-01,C8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,D10
NA,beta Cell Proliferation Inducer,NCGC00347958-01,F2
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G8
NA,beta Cell Proliferation Inducer,NCGC00347958-01,G9
